h. publications during the past three years...2003present editorial board member, drug design...

AMERICAN COUNCIL ON PHARMACEUTICAL EDUCATION

FORM F: Faculty Information

A. Information

Name: Stefan Balaz Date of Birth: 1/ 21/55

Department/Division: Pharmaceutical Sciences Licensed Pharmacist? No

First title at College: Research Associate Professor Date Appointed: 9/1/96

Current Title: Professor Date Appointed: 8/15/03

B. Estimated distribution of workload in the past year (%):

Activity Per Cent (%) Teaching: 40

Didactic 40 Experiential 0

Practice 0 Scholarly Activity 50 Committee Assignments 5 Student Advising 3 Faculty Mentoring 2 Administration 0 Other 0

Total 100 %

C. Teaching responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

PSCI 470/670: Pharmaceutics III: Pharmacokinetics, 3 credits in Fall semester, sole instructor PSCI 701: Quantitative Drug Design, 2 credits in Summer, sole instructor

D. Postsecondary/Professional Education _____________________________________________________________________________________ College Dates attended Degree earned College of Chemistry 10011974/06301979 MS Phys. Chem. Slovak University of Technology ______________________________________________________________________________________

E. Graduate Education ______________________________________________________________________________________ College Dates attended Degree earned College of Pharmacy 10011980/01311986 PhD Biochemistry

Comenius University (Slovakia) ______________________________________________________________________________________ College Dates attended Degree earned College of Pharmacy 10011990/06301994 DSc Pharm. Chem. Comenius University (Slovakia) ______________________________________________________________________________________

F. PostGraduate Training (postdoctoral training, residency, fellowship) ______________________________________________________________________________________ Institution Dates attended Position Institute for Exp. Biology & Medicine, Borstel (Germany) 06011988/09301989 Research Fellow ______________________________________________________________________________________ Institution Dates attended Position Institute for Exp. Biology & Medicine, Borstel (Germany) 06011990/09301990 Research Fellow ______________________________________________________________________________________ Institution Dates attended Position Liverpool John Moores University (UK) 07011991/08311991 Research Fellow ______________________________________________________________________________________ Institution Dates attended Position Fachhochschule RheinlandPfalz (Germany) 09011993/10311993 Research Fellow ______________________________________________________________________________________ Institution Dates attended Position Institute for Exp. Biology & Medicine, Borstel (Germany) 06011994/09301994 Research Fellow ______________________________________________________________________________________ Institution Dates attended Position National Water Research Institute, Burlington, ON 07011995/08311995 Research Fellow ______________________________________________________________________________________ Institution Dates attended Position University of Minnesota College of Pharmacy 02011996/09301996 Research Fellow ______________________________________________________________________________________

G. Previous Academic Positions ______________________________________________________________________________________ Institution Dates of Employment Position Slovak University of Technology College of Chemistry 02011986/03311990 Assist. Prof. ______________________________________________________________________________________ Institution Dates of Employment Position Slovak University of Technology College of Chemistry 04011990/12311995 Assoc. Prof. ______________________________________________________________________________________ Institution Dates of Employment Position Slovak University of Technology College of Chemistry 02011991/01311994 Graduate Dean ______________________________________________________________________________________ Institution Dates of Employment Position Slovak University of Technology College of Chemistry 01011996/09301996 Professor ______________________________________________________________________________________ Institution Dates of Employment Position North Dakota State University College of Pharmacy 10011996/08141999 Res. Assoc. Prof. ______________________________________________________________________________________ Institution Dates of Employment Position North Dakota State University College of Pharmacy 08151999/08142003 Assoc. Prof. ______________________________________________________________________________________

H. Publications during the past three years

1. Lukacova V., Zhang Y., Kroll D. M., Raha S., Comez D., Balaz S.: A comparison of the binding sites of matrix metalloproteinases and tumor necrosis factorα converting enzyme: Implications for selectivity. Journal of Medicinal Chemistry 48 (2005) 23612370.

2. Khandelwal A., Lukacova V., Comez D., Kroll D. M., Raha S., Balaz S.: A combination of docking, QM/MM Methods, and MD simulation for binding affinity estimation of metalloprotein ligands. Journal of Medicinal Chemistry 48 (2005) 5437 5447.

3. Khandelwal A., Lukacova V., Kroll D. M., Raha S., Comez D., Balaz S.: Processing multimode binding situations in simulationbased prediction of ligandmacromolecule affinities. Journal of Physical Chemistry A 109 (2005) 63876391.

4. Lukacova V., Khandelwal A., Zhang Y., Comez D., Kroll D.M., Balaz S.: Selectivity and affinity of matrix metalloprotease inhibitors. In: Modelling Structure and Reactivity in Biological Systems (Naidoo, K. J., Hann M., Gao J., Field M., and Brady J., eds.), The Royal Society of Chemistry UK (accepted).

5. Lukacova V., Zhang Y., Mackov M., Baricic P., Raha S., Calvo J.A., Balaz S.: Similarity of binding sites of human matrix metalloproteinases. Journal of Biological Chemistry 279 (2004) 1419414200.

6. Hu X., Balaz S., Shelver W.H.: A practical approach to docking of zinc metalloproteinase inhibitors. Journal of Molecular Graphics and Modeling 22 (2004) 293307.

7. Cook G.R., Manivannan E., Underdahl T., Lukacova V., Zhang Y., Balaz S.: Synthesis and evaluation of novel oxazoline MMP inhibitors. Bioorganic and Medicinal Chemistry Letters 14 (2004) 49354939.

8. Khandelwal A., Lukacova V., Kroll D. M., Comez D., Raha S., Balaz S.: Simulationbased prediction of binding affinities of matrix metalloproteinase inhibitors. QSAR and Combinatorial Science 23 (2004) 754766.

9. Lukacova V., Balaz S.: Multimode ligand binding in receptor site modeling: Implementation in CoMFA. Journal of Chemical Information and Computer Science 43 (2003) 20932105.

10. Tandlich R., Vrana B., Balaz S.: Monitoring of polychlorinated biphenyls in Slovakian freshwater sediments: use of semipermeable membrane devices. In: The Utilization of Bioremediation to Reduce Soil Contamination: Problems and Solutions (V. Sasek, J.A. Glaser, P. Baveye, eds.), pp. 221226, Kluwer Academic Publishers, Dordrecht, 2003.

11. Dercova K., Balaz S., Vrana B., Tandlich R.: Biodegradation of PCBs: metabolic pathway, distribution, kinetics and enhancement of efficacy. In: “The Utilization of Bioremediation to Reduce Soil Contamination: Problems and Solutions” (V. Sasek, J.A. Glaser, P. Baveye, eds.), pp. 95113. Kluwer Academic Publishers, Dordrecht, 2003.

12. Balaz S., Hornak V.: Multiple binding modes in threedimensional quantitative structureactivity relationships. In: Quantitative StructureActivity Relationships for Pollution Prevention, Toxicity Screening, Risk Assessment, and Web Applications (Walker J. D., ed.), pp. 107122, Society for Environmental Toxicology and Chemistry, Pensacola FL (2003).

I. Presentations during past 3 years

1. Computational approaches to design of selective metalloproteinase inhibitors with optimized distribution, Notre Dame University, March 16, 2005

2. Computational approaches to design of selective metalloproteinase inhibitors with optimized distribution, ScheringPlough, Cambridge, MA, August 2, 2005

3. Balaz S., Khandelwal A., Lukacova V.: A Combination of QM/MM Methods with MD Simulation for Binding Energy Estimation of Metalloprotein Ligands, 7 th Congress of the World Association of Theoretically Oriented Chemists, January 1621, 2005, Cape Town, South Africa (invited speaker)

4. Zhang Y., Lukacova V., Balaz S.: Quantitative characterization of binding of small molecules to extracellular matrix. AAPS National Biotechnology Conference, June 58, 2005, San Francisco, CA.

5. Khandelwal A., Zhang Y., Lukacova V., Underdahl T., Balaz S.: Kojic acid derivatives as matrix metalloproteinase inhibitors. AAPS National Biotechnology Conference, June 58, 2005, San Francisco, CA.

6. Zhang Y., Lukacova V., Balaz S.: Structural determinants of binding of small molecules to extracellular matrix. AAPS National Biotechnology Conference, June 58, 2005, San Francisco, CA.

7. Khandelwal A., Lukacova V., Balaz S.: Application of QM/MM method to binding affinity prediction of metalloprotein ligands. 4 th Engebretson Symposium on Drug Discovery and Development in Cancer Experimental Therapeutics, June 9, 2005, Minneapolis, MN

8. Zhang Y., Lukacova V., Wang T., Bartus V., Balaz S.: Binding of Small Molecules to Extracellular Matrix: A 3DQSAR Study. 4 th Engebretson Symposium on Drug Discovery and Development in Cancer Experimental Therapeutics, June 9, 2005, Minneapolis, MN

9. Zhang Y., Khandelwal A., Lukacova V., Underdahl T., Balaz S.: SlowBinding Kinetics of Matrix Metalloproteinase Inhibitors. 4 th Engebretson Symposium on Drug Discovery and Development in Cancer Experimental Therapeutics, June 9, 2005, Minneapolis, MN

10. Lukacova V., Peng M., Balaz S.: Prediction of Drug Partitioning in Regions of Phospholipid Bilayers. 4 th Engebretson Symposium on Drug Discovery and Development in Cancer Experimental Therapeutics, June 9, 2005, Minneapolis, MN

11. Khandelwal A., Lukacova V., Balaz S.: Binding affinities of metalloprotein ligands: QM/MM methods and multiple modes improve predictions, Computeraided Drug Design, Gordon Conference, Tilton, NH, July 31August 5, 2005, Tilton, NH

12. Lukacova V., Zhang Y., Balaz S.: Comparison of binding sites of TACE and MMPs. Computer aided Drug Design, Gordon Conference, Tilton, NH, July 31August 5, 2005, Tilton, NH

13. Lukacova V., Balaz S.: Fragment method for prediction of compound partitioning in phospholipid bilayers. Computeraided Drug Design, Gordon Conference, Tilton, NH, July 31 August 5, 2005, Tilton, NH

14. Balaz S.: Computational Chemistry and Biology Network, Internet 2 Day, April 1, 2004, Fargo, ND

15. Zhang Y., Balaz S.: Binding of matrix metalloproteinase inhibitors to extracellular matrix, 3 rd Engebretson Symposium, May 11, 2004, Fargo

16. Khandelwal A., Balaz S.: Simulationbased prediction of binding affinities of matrix metalloproteinase inhibitors, 3 rd Engebretson Symposium, May 11, 2004, Fargo

17. Lukacova V., Zhang Y., Balaz S.: A comparison of the binding sites of MMPs and TACE, 3 rd Engebretson Symposium, May 11, 2004, Fargo

18. Lukacova V., Cariveau N., Balaz S.: Solvation energies of organic compounds in different regions of phospholipid bilayers, 3 rd Engebretson Symposium, May 11, 2004, Fargo

19. Lukacova V., Balaz S.: Calorimetric analysis of solutebilayer interactions, 3 rd Engebretson Symposium, May 11, 2004, Fargo

20. Balaz S.: Computational tools for development of metalloprotein ligands, 3 rd Engebretson Symposium, May 11, 2004, Fargo

21. Balaz S.: Internet in pharmaceutical research and education, Symposium on Challenges in the Internet and Interdisciplinary Research, July 28 – August 2, 2004, Pescara, Italy

22. Grabher N., Lukacova V., Balaz S.: Determination of amphiphilicity as a factor in transbilayer transport, 225th National ACS Meeting, New Orleans, LA, March 2327, 2003.

23. Underdahl T., Lukacova V., Zhang Y., Balaz S.: Increasing throughput of MMP inhibitor testing, Fargo Conference on Metalloproteinases, Fargo, May 31 June 1, 2003

24. Zhang Y., Balaz S.: Characterization of binding behavior of MMP inhibitors to extracellular matrix, Fargo Conference on Metalloproteinases, Fargo, May 31 June 1, 2003

25. Lukacova V, Zhang Y., Mackov M., Baricic B., Balaz S.: A comparison of the binding sites of matrix metalloproteinases, Fargo Conference on Metalloproteinases, Fargo, May 31 June 1, 2003

26. Khandelwal A., Lukacova V., Balaz S.: Prediction of binding affinities of MMP Inhibitors, Fargo Conference on Metalloproteinases, Fargo, May 31 June 1, 2003

27. Khandelwal A., Lukacova V., Balaz S.: Multimode binding in the forcefieldbased 3DQSAR, Gordon Conference on Computer Aided Drug Design, July 2025, 2003, Tilton, NH

28. Tandlich R. and Balaz S., Nature of interaction of highly hydrophobic organic compounds with clay minerals, Fourth Annual Conference on Active Research by Environmental Science Students (CARESS), June 11, 2003, Weizmann Institute of Science, Rehovot, Israel

J. Present Scholarly Interests and Activities

Structurebased subcellular pharmacokinetics – experimental and computational elucidation of factors determining the rates and equilibria of the transbilayer transport, creation of structure based models of subcellular pharmacokinetics containing transbilayer transport, metabolism, binding to major proteins (albumin, collagen, Gactin), hydrolysis and renal excretion.

Development of methods for structurebased prediction of binding affinities by a combination of molecular dynamics and quantum mechanics.

Development of methods for a comparison of flexible binding sites of related enzymes and receptors with the aim to discern the features of ligands leading to selectivity.

Development of selective inhibitors of matrix metalloproteinases with optimized distribution using the approaches of structurebased subcellular pharmacokinetics.

Development of webbased tools for the improvement of education in pharmacokinetics and drug design

Creative use of Personal Response System and the Blackboard web system tools for the improvement of education in pharmacokinetics and drug design

K. Present Professional Interests and Activities

2000present Board member (web site and treasure), QSAR and Modeling Society 2000present member, American Chemical Society 2001present member, Biophysical Society 2001present member, American Association of Colleges of Pharmacy 2003present Editorial Board member, Drug Design Reviews Online (Bentham) 2003present Editorial Board member, QSAR and Combinatorial Science (WileyVCH) 2004present Editorial Board member, Current ComputerAided Drug Design (Bentham) 2004present Editorial Board member, Medicinal Chemistry (Bentham) 1990present reviewer for Journal of Medicinal Chemistry, Journal of Pharmaceutical

Sciences, Journal of Chemical Information and Computer Science, Journal of Molecular Graphics and Modeling, Theochem, Environmental Toxicology and Chemistry, SAR and QSAR in Environmental Science, Advances in Environmental Research

1998present reviewer of grant applications for the American Chemical Society Petroleum Research Fund, Fulbright Commission, and Slovak Grant Agency



A. Information

Name: Robert Biberdorf Date of Birth: 121753

Department/Division: Pharmacy Practice Licensed Pharmacist? Yes State: ND

First title at College: Instructor Date appointed: June 1984

Current title: Assistant Professor Date appointed: June 1986


Activity Per cent (%) Teaching: Didactic

25

Experiential 35 Practice 30 Scholarly activity 5 Committee assignments 5 Student advising 0 Faculty mentoring 0 Administration 0 Other:

Total 100%

C. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Phrm 558: Gastrointestinal and Nutrition Phrm 534: Endocrine/Rheumatology

D. Postsecondary/Professional Education

College Dates attended Degree Earned North Dakota State University 9/1971 – 8/1975 B.S. Pharmacy

E. Graduate Education (Master of Science, Doctor of Philosophy)

College Dates attended Degree Earned

North Dakota State University 7/1976 – 6/1978 M.S. Hospital Pharmacy

F. PostGraduate Training (postdoctoral training; residency, fellowship)

Institution Dates attended Position Veterans Administration 7/19766/1978 Pharmacy Resident

G. Previous Academic Positions

Institution Dates of employment Position University of Wyoming 7/1978 – 7/1979 Assistant Professor of Pharmacy Practice

H. Publications during past 3 years Albertson,B, Biberdorf R.,Aronson, M: Phosphate binding capabilities of colesevelam, a bileacid sequestrants with chemical similarities to sevelamer, ASHP Midyear Clinical Meeting, December 2003

Hanley, J, Willardson, D, Biberdorf, R.: Profound Hypoglycemia in a MailOrder Pharmacy Customer as a result of Dispensing Error, Hospital Pharmacy Vol 37 #7, 734736


“Pharmacy Environment Present and Future: Nursing Pharmacy Collaboration to Improve Patient Care”, Advancing Nursing Practice Fargo, ND, April 2005

“Herbal therapies in diabetes..Benefits and Risks”, Diabetes Education Center – Fargo ND, January 2005

“Strategies for Reducing Medication Errors”, Challenge 2004: Creating a Patient Safety Culture – Fargo, ND, October 2004

“Reviewing your Medications”, Diabetes Patient Seminar – Fargo ND, September 2004

“Therapeutic Drug Monitoring” NDSU/MeritCare Med Tech Program – Fargo ND, February 2004

“Patient Safety Goals 2004” MeritCare Care Professional Nursing Seminar, MeritCare Health System – Fargo ND, November 2003

“Treatment of Diabetes in Children” NDSU Pharmacy Homecoming Seminar – Fargo ND, October 2003

“Focused on patient safety: Strategies for leaders” MeritCare Health System – Fargo ND, June 2003 (4 lectures)

“Applying FMEA to transfer of patients to different acuity levels,” as part of Patient Safety 2002: From Analysis to Action. VHA Upper Midwest – Bloomington, MN, November 2002

“The Future of Health Care” Panel Discussion, Upper Great Plains Technology Conference & Trade Show – Fargo ND, October 2002

“Utilization of Robotics in Providing Pharmacy Services”, American Association of Pharmacy Technicians – Fargo, ND, August 2002



Developing model for integrating pharmacy services into care coordination



A. Information

Name: Wendy Brown Date of Birth: 7/16/76

Department/Division: Pharmacy Practice Licensed Pharmacist? Yes State: ND, MN

First title at College: Assistant Professor Date appointed: 7/1/02

Current title: Assistant Professor Date appointed: 7/1/02



30

Experiential 25 Practice 25 Scholarly activity 10 Committee assignments 5 Student advising 5 Faculty mentoring Administration Other:

Total 100%

D. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Phrm 534: Hormone Replacement, Infertility, Contraception, Addison’s Disease Phrm 538: Cardiovascular and Pulmonary Pharmacotherapeutics (Instructor Pulmonary Therapeutics and Course Coordinator) Phrm 300: Principles of Clinical Pharmacology (Pulmonary and Endocrinology Instructor) Phrm 551: Pharmaceutical Care V Physical Assessment, Patient care monitoring, Ambulatory Selftesting devices Instructor

Concept Lab Case Facilitator: Asthma, COPD, Contraceptives, HRT Current Concepts in Pharmacy Practice Instructor (Elective course) Family HealthCare Center Ambulatory Care Adult Medicine Rotation Preceptor

E. Postsecondary/Professional Education

College Dates attended Degree Earned North Dakota State University Aug. 1994May 2000 B.S. Pharmaceutical Sciences

College Dates attended Degree Earned North Dakota State University Aug. 2000 May 2001 Pharm.D.




Institution Dates attended Position Dakota Pharmacy NACDS/ NCPA Community Pharmacy Aug. 2001 May 2002 Resident Practice Residency


Institution Dates of employment Position

H. Publications during past 3 years

September 2005 Pharmacological Management of Gestational Asthma. U.S. Pharmacist

October 2003 Developed a health provider Asthma Desk Guide and North Dakota Asthma Action Plan that was peer reviewed through the North Dakota Asthma Work Group. Desk guide and asthma action plan were disseminated to 2,451 health professionals in the state of North Dakota and 62 Center for Disease Control asthma contacts. http://www.health.state.nd.us/asthma/


Posters:

October 2005 “PointofCare Testing to Promote” Poster Presentation ACCP Annual Meeting

November 2004 “Improving Patient Awareness of Asthma Symptoms” Poster Presentation Community Health Associations of Mountain/Plain States (Region 8) Phase 2 meeting sponsored by the Bureau of Primary Health Care Dallas, Texas

July 2004 “Improving Patient Awareness of Asthma Symptoms” Poster Presentation 2004 Association of Asthma Educators Conference Philadelphia, Pennsylvania

April 2004 “Bridging the Gap between National Guidelines and Clinical Practice” Poster Presentation 2004 National Asthma Conference sponsored by the Center for Disease Control and Prevention Atlanta, Georgia

Invited Presentation: July 2005 “Basic Pharmacology Asthma”

“Advanced Pharmacotherapy Asthma” Association of Asthma Educator Conference Las Vegas, NV

May 2005 “ND Pharmacy Association Disease Management Proposal” Healthy North Dakota 3 rd Party Payer Committee Meeting. Fargo, ND

March 2005 “Master Home Environmentalist” Weather Conference Grand Forks, ND

November 2004 “Optimizing Care for Patients with Asthma” North Dakota Nursing Association Conference Fargo, North Dakota

March 2004 “Easing the Urge Products that Promote Tobacco Cessation” Patterson Dental Little Chicago Dental Event Fargo, North Dakota

February 2004 “Asthma in the Elementary School” Kindred Elementary Kindred, North Dakota

January 2004 “The Use of Leukotriene Receptor Blockers in Childhood Asthma” North Dakota Asthma Workgroup Bismarck, North Dakota

October 2003 “Budesonide Inhalation Suspension (Pulmicort Respules) What is the maximum effective dosage for infants?” North Dakota Asthma Workgroup Bismarck, North Dakota

October 2003 Management of Asthma using the National Institutes of Health Guidelines, Revised 2002 North Dakota Department of Health Web cast panel member Bismarck, North Dakota

May 2003 “Asthma in the Pediatric Patient” Headstart Conference

Fargo, North Dakota October 2002 “Asthma and Comorbid Conditions”

NDASP (North Dakota Association of School Psychologist) Fargo, North Dakota

Consultant for American Lung Association of North Dakota Eastern Region Coordinator Aug. 20042005. Position required coordinating and implementing the outreach programs, fund raising, volunteer development, communications, training, and coalition representation functions for the eastern region of North Dakota.


In Progress “Peak Flow Monitoring, Medication Incorporation, Maintaining Asthma Devices, Exercise Induced Bronchospasm.” Web based education for health provider as part of Senate Bill 2163 which allow students to carry self inhalers and epipens Bismarck, North Dakota

In Progress “Linking Families to Local Asthma Experts” Revising for future journal submission


Pharmacist directed Disease Management Programs

Medication Therapy Management Services

Point of Care testing for underserved population



A. Information

Name: Satadal Chatterjee Date of Birth: 2/28/1954


First title at College: Associate Professor Date appointed: 3/1/2004

Current title: Associate Professor Date appointed: 3/1/2004



40

Experiential Practice Scholarly activity 40 Committee assignments 8 Student advising 1 Faculty mentoring 1 Administration Other:

Total 100%

F. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Instructor: Spring 2004, PSCI 411/611 4 Hours Instructor: Fall 2004, PSCI 412/612 23 Hours Instructor: Fall 2005, PSCI 412/612 23 Hours Instructor: Spring 2006, PSCI 415/615 22 Hours

G. Postsecondary/Professional Education

College Dates attended Degree Earned Ramakrishna Mission Boys' Home 1975 B.Sc.,Physic (Honors)

University of Calcutta, India

H. Graduate Education (Master of Science, Doctor of Philosophy)

College Dates attended Degree Earned Science College 1977 M.Sc., Physics University of Calcutta, India

College Dates attended Degree Earned Saha Institute of Nuclear Physics 1986 Ph.D., Physics University of Calcutta, India

I. PostGraduate Training (postdoctoral training; residency, fellowship)

Institution Dates attended Position Case Western Reserve University 19851989 Research Associate Cleveland, Ohio


PROFESSIONAL APPOINTMENTS: (All of the following appointments, unless noted, are in Hem/Onc division, Department of Medicine)

Institution Dates of employment Position Case Western Reserve University 19891992 Instructor

Institution Dates of employment Position Case Western Reserve University 19932004 Assistant Professor

G. Publications during past 3 years

1. Hirota, H., Gosky, D., Berger, N. A. and Chatterjee, S. Deficiency of topoisomerase IIα is associated with increased susceptibility to melphalan. Int J Oncology 20: 311318, 2002.

2. Chatterjee,S. Resistance or sensitivity to anticancer drugs: An emerging arena involving stress protein GRP78, Recent Research Developments in Cancer (Vol. 4), 161176, Transworld Research Network, 2002.

3. Gosky, D. and Chatterjee, S. Downregulation of topoisomerase IIα is caused by up regulation of GRP78. Biochem. Biophys. Res. Commun. 300: 327332, 2003.

4. Chatterjee, S. Consequences of interference with niacin metabolism: Can we exploit it to decipher cancer chemopreventive potential of niacin? Recent Research Developments in Biochemistry, Transworld Research Network , In press,.

I moved from Case Western Reserve University and joined NDSU on March 1, 2004. This transition resulted in a significant loss of manpower and time. Further, it disrupted the pace of my research activity. It took a while and consumed lot of my efforts to transform my lab at NDSU from a nonfunctional state to a functional one. Therefore, we could not publish in a peerreviewed journal during this period. However, following please find a list of manuscripts that we expect to publish in 2006.

1. Chatterjee, S. Niacin deficiency in normal human lung cells causes depletion of p53 levels. To be resubmitted in Cancer Research.

2. Gaddameedhi, S., Hirota, H., and Chatterjee, S. Identification of genes contributing to enhanced sensitivity to anticancer drugs and to mutator phenotype due to the deficiency of topoisomerase IIα. To be submitted in Science

3. Gaddameedhi, S., Ahmed, M.E., and Chatterjee, S. Identification of genes associated with cell cycle, apoptosis and signal transduction pathways in A549 human lung cancer cells after upregulation of glucose regulated protein of Mr78KDa (GRP78) and DNA damage. In preparation and to be submitted in Nature

4. Ahmed, M.E. and Chatterjee, S. GRP78 (glucose regulated protein of Mr 78 Kda) can serve as a novel target for therapy of cancers irrespective of the nature of mutations; a mechanistic study. In preparation and to be submitted in EMBO J.

5. Ahmed, M.E. and Chatterjee, S. Mechanisms that associate sensitivity of various ovarian cancer cells to cisplatin with induction of GRP78 (glucose regulated protein of Mr 78 Kda). In preparation and to be submitted in Molecular Pharmacology.

6. Ahmed, M.E. and Chatterjee, S. Hypersensitization of A549 human lung cancer cells with melphalan following upregulation of GRP78. In preparation and to be submitted in Int. J. Cancer.

7. Reindl, K., Gaddameedhi, S, and Chatterjee, S. Differential expression of tumor metastasis genes in prostate cancer cell lines derived by repeated metastasis. In preparation and to be submitted in PNAS.

8. Lohani, M., Ahmed, M.E., and Chatterjee, S. Genetic alterations resulting from exposure to tobacco specific carcinogen NNK under niacin deficiency: Potential of niacin as a cancer preventive agent. In preparation and to be submitted in Journal of the National Cancer Institute.

9. Berger, S. J., Chatterjee, S., Tsai, ML., Gosky, D., Zborowska, E., Markowitz, S., Willson, J. K. V., and Berger, N. A. Topoisomerase I and II activity in human colon

cancer specimens and tissue culture cell lines. To be resubmitted in Clinical Cancer Research.

H. Presentations during past 3 years (excluding numerous abstracts):

INVITED SPEAKER:

2/2002 Department of Molecular Biology, University of Calcutta, Calcutta, INDIA. Faculties, Postdocs, Graduate students and Research assistants. TITLE: Role of niacin in prevention of carcinogenesis

4/2002 Department of Pathology and Cancer Center, University of Illinois at Chicago, Chicago, IL Faculties, Postdocs, Graduate students and Research assistants. TITLE: Mechanisms of resistance or sensitivity to clinically useful anti cancer drugs

9/2003 Department of Pharmacy, North Dakota State University, Fargo, ND. Faculties, Postdocs, Graduate students and Research assistants. TITLE: Can stress protein serve as a target for cancer chemotherapy?

GUEST SPEAKER:

5/2003 Poly (ADPribose) Polymerase as novel therapeutic targets: Lisbon, Portugal. Internationally recognized scientists from almost 15 countries and many Pharmaceutical Industries. TITLE: Involvement of glucose regulated stress protein of Mr 78 kDa (GRP78), topoisomerase IIα in Poly (ADPribose)mediated response to DNA damage inflicted by anticancer agents.

5/2004 Engebretson Symposium, Hosted by NDSU: Graduate students, Post doctoral fellows, and Faculties from NDSU, University of Minnesota, and Mayo Clinic. TITLE: DNA Topoisomerase II alpha revisited

6/2005 Engebretson Symposium, Hosted by University of Minnesota: Graduate students, Postdoctoral fellows, and Faculties from NDSU, University of Minnesota, and Mayo Clinic. TITLE: Molecular mechanisms responsible for hypersensitivity to Cisplatin after upregulation of GRP78 (Glucose regulated stress protein of Mr 78 kDa)

I. Present Scholarly Interests and Activities

Serving as a Mentor for the Following Post Doctoral Fellows, and Graduate Students:

2002 – 6/2005 Mohammad Equebal Ahmad, Ph.D. (Postdoctoral Research Associate) GRP78 upregulation and sensitivity to

alkylating agents 7/2004 Shobhan Gaddameedhi (Ph.D. Candidate) Molecular genetics of

topoisomerase II 4/2004 Katie Reindl (Ph.D. Candidate) Molecular mechanisms of

Prostate Cancer metastasis

12/2004 Hongmei Niu (Ph.D. Candidate) Molecular genetics of breast cancer

10/2004 Srikanth Nagalla, M.D. (MeritCare Hospitals) Identification of genes altered

in various(Parttime PostDoctoral Fellow) kinds of cancer

EXTRAMURAL GRANTS FUNDED IN LAST THREE YEARS (As Principal Investigator):

2/01/2001 – 1/31/2007 P. I. Satadal Chatterjee, Ph.D. Source of Funding: National Cancer Institute/National Institutes of Health

RO1CA6592010 (ACTIVE) Direct Costs: $675,000; Total Costs: $1,032,750 Total years of project: 6

7/31/2001 2/28/2004 P. I. Satadal Chatterjee, Ph.D. Source of Funding: American Institute for Cancer Research

Direct Costs: $150,000; Total Costs: $165,000 Total years of project: 2 YEARS and 7 MONTHS

Role of niacin as a chemopreventive agent in lung cancer

INTRAMURAL GRANTS FUNDED (As Principal Investigator)

5/01/2004 4/31/2005 P.I. Satadal Chatterjee, Ph.D. Source of Funding: NDSU EPSCoR

Direct Costs: $50,000, Total Costs: $71,000 3/01/2004 4/15/2005 P.I. Satadal Chatterjee, Ph.D. Source of Funding: BRIN

Direct Costs: $50,000

J. Present Professional Interests and Activities

A) STUDY SECTIONS:

19971998 Susan G. Komen Breast Cancer Foundation 19982002 American Cancer Society

B) PROFESSIONAL SOCIETIES:

1992 American Association for Cancer Research

1993 Ireland Comprehensive Cancer Center of the University Hospitals of Cleveland (Developmental Therapeutics)

2001 American Association for the Advancement of Science 2004 American Association of Colleges of Pharmacy

C) OTHER:

Reviewer of Scientific Journals: 1995 Cancer Research 1996 Journal of Biological Chemistry 1999 Biochemical Pharmacology 2000 FEBS Letters 2002 EMBO J 2002 Clinical Cancer Research 2004 BBA Biochimica et Biophysica Acta (General Subjects) 2005 Archives of Environmental Contamination and Toxicology 2005 Oncogene

D)

2004 Have been teaching Professional Pharmacy Students at NDSU part of the “Pharmacodyanamics” course

2004 1) Faculty search committees Chaired by Drs. Stephan Balaz, and Steven O’Rourke;

2) College Academic Standards Committee; 3) ND EPSCoR Doctoral Dissertation

Award Program (served as a Reviewer, 2005); 4) NDSU Dean of Graduate Studies’ Recognition of Graduate Students Award Program (served as a Reviewer, 2005)



A. Information

Name: Mark Dewey Date of Birth: 6/14/75

Department/Division: Pharmacy Practice Licensed Pharmacist? Yes State: MN/ND





10


Total 100%

J. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Pharm 558: Gastroenterology, 3 credits Pharm 300: Principles in Clinical Pharmacology, 3 credits


College Dates attended Degree Earned Bachelor of Pharmaceutical Sciences

North Dakota State University 19951999 Doctorate of Pharmacy


North Dakota State College of Science 19931995 Associate Degree of Science




Institution Dates attended Position



H. Publications during past 3 years: None.


Understanding Insulin (Numerous 20042005) Update on Hypoglycemic agents (20042005) Osteoporosis (2004) Proper use of Narcotics (2003)

J. Present Scholarly Interests and Activities: Coinvestigator on Dakota Geriatric Education Center Grant that has received funding for 20052010.

K. Present Professional Interests and Activities: Geriatrics, Medication Therapy Management, Medication Errors.

Professional Affiliations • American Society of Consultant Pharmacists • American Pharmacists Association • Minnesota Pharmacists Association • North Dakota Pharmacists Association • American Society of HealthSystem Pharmacists • Rho Chi

Awards

2000 APhA Foundation Incentive Grant for Practitioner Innovation In Pharmaceutical Care 2005 Minnesota Distinguished Young Pharmacist Award



A. Information

Name: Amy Drummond Date of Birth: 11/01/70






15

Experiential 25 Practice 40 Scholarly activity 5 Committee assignments 10 Student advising 5 Faculty mentoring Administration Other:

Total 100%

K. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

University Studies 189 Skills for Academic Success Pharmacy 300 Principles of Clinical Pharmacology Pediatric and Neonatal Pharmacology Pharmaceutical Sciences 471 Clinical Pharmacokinetics – Pediatric and Neonatal Kinetics


College Dates attended Degree Earned North Dakota State University 19941996 Doctor of Pharmacy


North Dakota State University 19891994 B.S. Pharmaceutical Science




Institution Dates attended Position The Children’s Hospital 19971998 Pediatric Specialty Resident Denver, CO

Institution Dates attended Position St. Alexius Medical Center 19961997 Pharmacy Practice Resident Bismarck, ND




Patterson, B. and Drummond, A. Perspectives in Pediatric and Adolescent Health: Depression. Pharmat, Inc. pp 120, 2005.


Introduction to Pediatric Pharmacotherapy Children’s Health Homecoming Seminar, Annual College of Pharmacy Continuing Education Seminar North Dakota State University, Fargo, ND Speaker

Stimulant Treatment of Attention Deficit Hyperactivity Disorder Various clinics; Fargo, ND Speaker

Gastroesophageal Reflux Cystic Fibrosis Association; Fargo, ND Presentation to Support Group


Pediatric Oral Dosage Formulations


Pediatric Pharmacy Advocacy Group – Member Healthy Pregnancy Task Force Member



A. Information

Name: Jeanne Frenzel Date of Birth: 02/25/77

Department/Division: Pharmacy Practice Licensed Pharmacist? Yes State: ND/MN

First title at College: Assistant Professor Date appointed: July 2004

Current title: Assistant Professor Date appointed: July 2004


Activity Percent (%) Teaching: Didactic

60

Experiential Included in above figure Practice 20 Scholarly activity 5 Committee assignments 5 Student advising 5 Faculty mentoring 0 Administration 5 Other:

Total 100%

L. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Phrm 351/352: Pharmaceutical Care (Concept Pharmacy) Phrm 451/452: Pharmaceutical Care (Concept Pharmacy) Phrm 452: Pharmaceutical Care 452 (Lecture) Phrm 551/552: Pharmaceutical Care (Concept Pharmacy) Phrm 300: Principles of Clinical Pharmacology Phrm 170: Common Medicines and Diseases Coordinator, First Year Professional Student Service Learning Program Mentor, Third Year Professional Student Service Learning Experiential Preceptor, Academic Rotation Academic Advisor Hospital Pharmacist, MeritCare Hospital Pharmacy


College Dates attended Degree Earned North Dakota State University August 1995 – May 2003 Pharm.D. College Dates attended Degree Earned North Dakota State University August 1995 – May 2003 B.S.Pharmaceutical Sciences College Dates attended Degree Earned North Dakota State University August 1995 – May 2003 B.S. Microbiology




Institution Dates attended Position Veterans Affairs Medical CenterJune 2003 – July 2004 Pharmacy Practice Resident



H. Publications during past 3 years § Frenzel J, Koo J, Lo S, Kaul R, Chadha A. Factors Related to Microalbuminuria in Non

Diabetic Elderly Males with Normal Renal Function. Hospital Pharmacy. 2005;40.

I. Presentations during past 3 years § Zoledronic acid (Zometa) Drug Information Presentation

Veterans Affairs Medical Center Presented education to Primary Care nursing staff detailing the indication, correct use, and adverse drug effects of new formulary medication.

J. Present Scholarly Interests and Activities § Develop dispensing, consultation, personal digital assistant, compounding, and intravenous

admixture activities which promote critical thinking § Analyze and assess the critical thinking of students learning within the Concept Pharmacy § Analyze the longitudinal development of student learning within the Concept Pharmacy § To become a Board Certified Pharmacotherapy Specialist with an emphasis in

Pharmacotherapy

K. Present Professional Interests and Activities § Maintain practice at MeritCare South University Hospital Pharmacy, Fargo, ND. § 2005 TriState Leadership Conference § Big Iron 2005: Public health screenings – lipid profiles, blood glucose, blood pressure



A. Information

Name: Bin Guo Date of Birth: 11/26/1968






40

Experiential Practice Scholarly activity 50 Committee assignments 5 Student advising 5 Faculty mentoring Administration Other:

Total 100%

M. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences):

Psci 413: Pharmacodynamics and Applied Therapeutics III, 3 credits Psci 415: Pharmacodynamics and Applied Therapeutics V, 3 credits Psci 416: Pharmacodynamics and Applied Therapeutics VI, 3 credits


College Dates attended Degree Earned University of Science and Technology of China 1987 – 1992 B.S.


College Dates attended Degree Earned State University of New York at Buffalo 19931999 Ph.D.


Institution Dates attended Position Burnham Institute 19992003 Postdoc Fellow




1. Guo B., Zhai D., Cabezas E., Welsh K., Nouraini S., Satterthwait A., and Reed J.C. 2003 Humanin Suppresses Apoptosis by Interfering with Bax Activation. Nature 423, 456 – 461.

2. Zhai D., Luciano F., Zhu X., Guo B., Satterthwait A.C., Reed J.C. 2005 Humanin binds and nullifies Bid activity by blocking its activation of Bax and Bak. Journal of Biological Chemistry 280(16):1581524.

I. Presentations during past 3 years Invited speaker, 4th Engebretson Symposium on Drug Discovery and Development in Cancer Experimental Therapeutics, University of Minnesota, Minneapolis, MN June 9, 2005.

Minisymposium Presentation, 94th Annual Meeting of American Association for Cancer Research (AACR), Washington D.C., July, 2003.

J. Present Scholarly Interests and Activities Research on mechanism of Bax activation in apoptosis, supported by an NIH R21 grant.

Research on a novel proapoptotic peptide, supported by a Department of Defense Concept Award.

K. Present Professional Interests and Activities Teaching Pharm.D. students and graduate students.



A. Information

Name: Kimberly Vess Halbur Date of Birth: 01/14/1971

Department/Division: Pharmacy Practice/Dean’s Office Licensed Pharmacist? No

First title at College: Assistant Dean/Assistant Professor Date appointed: 7/1/04

Current title: Assistant Dean/Assistant Professor Date appointed: 7/1/04



5

Experiential Practice Scholarly activity 10 Committee assignments 15 Student advising Faculty mentoring 5 Administration 65 Other:

Total 100%

N. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Phrm 462—Stress Management for Health Professionals (cotaught with Dr. Schmitz) Phrm 352Ethics lectures (4 hours) UNIV 189Study Skills P1 Service Learning, mentor


College Dates attended Degree Earned Ball State University 8/895/93 B.S.


College Dates attended Degree Earned University of Cincinnati 6/933/95 M.A. College Dates attended Degree Earned Purdue University 8/955/96 University of Cincinnati 8/966/98 Ed.D.




Institution Dates of employment Position University of Northern Iowa 8/20006/2004 Assistant Professor University of San Diego 8/19997/2000 Visiting Assistant Professor Wabash College 6/19987/1999 Asst. DirectorCareer Services


Halbur, D. A. & Halbur, K.V. (2005). Developing your theoretical orientation in counseling and psychotherapy. Boston, MA: Allyn & Bacon Publishing.

Vess, K. A., & Halbur, D. A. (2004). Review of DeLuciaWaak and Donigian’s The Practice of Multicultural Group Work: Visions and perspectives from the field. The group worker.

Vess, K. A., & Halbur, D. A. (2003). Character Education in Counseling: A Call to Counselor Educators. ERIC/CASS Digest. Greensboro, NC: The ERIC Clearinghouse on Counseling and Student Services.

Vess, K. A. (2003). Hope for College Counselors. [Review of the book College Counseling in the New Millennium]. Counseling Today.

Vess, K. A. (2002). Using servicelearning to teach counseling. The Dakota Counselor.

Vess, K. & Drury, A. (2002). M&M Game. Group work experts share their favorite activities: A guide to choosing, planning, conducting and processing, pp. 3536.

Vess, K. & Funke, M. (2002). Stress Jenga. Group work experts share their favorite activities: A guide to choosing, planning, conducting and processing, pp. 7172.


Mobbing as part of Counselor Education: Understanding Emotional Abuse in the Workplace. Presentation for the Association of Counselor Educators and Supervisors Conference, Pittsburgh, PA, October 2005. Copresenting with Dr. Duane Halbur

Supervision of Testing. Presentation for the Association of Counselor Educators and Supervisors Conference, Pittsburgh, PA, October 2005. Copresenting with Dr. Margery Shupe and Dr. Duane Halbur

Using Narrative Approaches in Career Guidance. Poster presentation at the International Education Conference Honolulu, HI. January 2005. Copresented with Dr. Duane Halbur.

Mobbing in Higher Education

Presentation at the International Education Conference, Honolulu, HI January 2005. Copresented with Dr. Duane Halbur

Stress Management for Health Professionals

Twoday workshop, invited speaker, for Dakota Drug Annual Continuing Education in Maui, HI. January 2005. Copresented with Dr. Duane Halbur

The Art and Science of Theoretical Orientation: How to Develop and Solidify Yours

Blue ribbon program for the American Counseling Association conference

April 2004. Copresented with Dr. Duane Halbur, Ms. Molly Wertz and Ms. Kristin Schloemer

Beginning, Middle and End: Evaluating Student Progress in Counselor Education Programs 2002 National ACES Conference, Park City, UT—October 20, 2002 Copresented with Dr. Ann Vernon, Dr. Duane Halbur and Dr. Roberto Clemente

Beginning, Middle and End: Evaluating Student Progress in Counselor Education Programs 2002 American Counseling Association Conference, New Orleans, LA Copresented with Dr. Ann Vernon and Dr. Duane Halbur

Characteristics of Effective Counselors: A QMethodology Study 2002 American Counseling Association Conference, New Orleans, LA

Copresented with Dr. Duane Halbur and Ms. Lana Poppen

Advancing Your Knowledge of Philosophical Counseling

Minnesota Counseling Association, Regional Workshop, November 2004.

Philosophical Counseling

2004 North Central Association of Counselor Educators and Supervisors Conference, St. Louis,

MO. Copresented with Dr. Duane Halbur

Developing and Solidifying Your Theoretical Orientation

2003 North Central Association for Counselor Education and Supervision Conference, Cincinnati, OH. Copresented with Dr. Duane Halbur

Using Leadership Skills to Empower Your Crew Keynote address at the Iowa Society of Human Resource Manager’s Annual Meeting December 10, 2002, Ames, IA

Developing and Solidifying Your Theoretical Orientation

University of Iowa’s Summer School for Helping Professionals, August 56, 2002 Copresented with Dr. Duane Halbur

Walking on Eggshells: Working with Borderline Clients

2002 Iowa Mental Health Counselors Association Annual Conference, Waterloo, IA

Copresented with Deginesh Worku, MA, LMHC


Stress, Critical thinking and quality of life among pharmacy students

Anxiety and depression levels of professional students Faculty workload


Multicultural affairs, admissions, student affairs NASPA, ACA, ACES, NACADA member



A. Information

Name: Anne Hinderliter Date of Birth: 2/2/66


First title at College: Assistant Professor Date appointed: August 2000

Current title: Assistant Professor Date appointed: August 2000



40

Experiential 2 Practice Scholarly activity 50 Committee assignments 6 Student advising 2 Faculty mentoring Administration Other:

Total 100%

O. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences) PSci 368: Pharmaceutics I, 4 credits, 60 hrs/semester PSci 411/611: Pharmacodynamics and Applied Therapeutics I, 3 credits PSci 796: Special Topics, 3 credits, 45 hours/semester (this is a new graduate course)


College Dates attended Degree Earned University of WisconsinMadison 19841988 Ch.C


College Dates attended Degree Earned Cornell University 19881994 Ph.D


Institution Dates attended Position University of Virginia 19941996 NIH Fellowship

Institution Dates attended Position University of Virginia 19962000 postdoctoral training




Frazier, A.A., Roller, C.R., Havelka, J.J., Hinderliter, A. and D.S. Cafiso. 2003. Membrane bound orientation and position of the synaptotagmin I C2A domain by sitedirected spin labeling. Biochemistry. 42:96105.

Hinderliter, A., Biltonen, R.L. and P.F.F. Almeida. 2004. Lipid modulation of proteininduced membrane domains as a mechanism for control of signal transduction. Biochemistry 43:7102 7110.

Rufener, E., Frazier, A.A., Wieser, C.M., Hinderliter, A., and D.S. Cafiso. 2005. Membrane bound orientation and position of the synaptotagmin C2B domain by sitedirected spin labeling. Biochemistry 44:1828.

Almeida, P.F.F., Sohma, H., Rasch, K.A., Wieser, C.M., and A. Hinderliter. 2005. Allosterism in membrane binding: a common motif of the annexins? Biochemistry 44:1090510913.

I. Presentations during past 3 years Invited Presentations: Invited speaker to the Institute of Theoretical Chemistry, “Lipid Modulation of ProteinInduced Membrane Domains as a Mechanism for Control of Signal Transduction”. University of Wisconsin Madison, July 27, 2004.

Invited speaker to the University of Florida, Department of Chemistry, “Small in Size and Cooperative in Nature: Do LipidLipid Interactions Dictate How the Cell Signals,” Sept. 2930 th . 2005. I will be giving a research seminar as well as my research being the discussion topic for the chemistry graduate student’s journal club.

Invited speaker to Pennsylvania State University, Department of Chemistry, State College, Pennsylvania, spring 2006.

Presentations at Professional Meetings:

Invited speaker Invited speaker to International Annual Biophysical Society Meeting, I will give an awards research seminar as well as accept the Dayhoff Award at the Keynote Speech and Awards Symposium, Salt Lake City, Utah, Feb. 2328, 2006.

Invited speaker to Third International Annexin Conferences on ‘Allosterism in Membrane Binding: a Common Motif of the Annexins?’, Ascona, Switzerland, March 2024, 2005.

Invited speaker to Second International Annexin Conference on “Molecular and Cellular Physiology of the Annexins” on ‘Do Annexins Regulate Membrane Domain Formation?’ University of Calgary, Calgary, March 2225, 2003.

Presenter and Discussant

Biophysical Discussions, Probing Membrane Microdomains, Asilomar, CA Oct. 2831, 2004. The effect of temperature on lipid domain sizes and its consequences for the existence and isolation of rafts by the detergent extraction method at low temperatures. Anne Hinderliter and Paulo F. Almeida.

Partial Phase Diagrams of Ternary Raft System (Sphingomyelin/POPC/Cholesterol) Studied by dLysin Induced Dye Efflux and DSC. Application to Red Blood Cell Membranes. Antje Pokorny, Anne Hinderliter and Paulo F.F. Almeida.


My research seeks to test the hypothesis that lipidlipid interactions are by nature weak, cooperative, and transient so as to create an on/off switch for signaling events at the membrane surface. The use of lipids offers the possibility of cooperativity in the assembly of protein complexes on the membrane and of finetuning the combinations of proteins that will subsequently be assembled.

To both broach and answer this question, as to whether lipid diversity exists as a means to alter cellular outcomes by modulating a membraneinvolving signaling event, requires merging of the disciplines of membrane biophysics, thermodynamics, protein purification and modification, statistical thermodynamics (binding partition functions), and pharmacology.

I seek to address questions regarding the underlying principles that dictate how membrane domains form, how the bilayers couple, how membrane domains are regulated, and application of the answers to systems of neuropharmacological importance (the synaptotagmins).


Training PharmD students in basic research has a means to populate the next generation of academic scientists within the profession.



A. Information

Name: Wanda Kearney Date of Birth: 3/30/47

Department/Division Pharmacy Practice Licensed Pharmacist? Yes State: ND/MN

First title at College: Director of Experiential Programs Date appointed: 10/6/03

Current title: Director of Experiential Programs Date appointed: 10/6/03



20

Experiential 50 Practice Scholarly activity Committee assignments 10 Student advising 20 Faculty mentoring Administration Other:

Total 100%

P. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Phrm 475: Pharmacy Practice Management, 3 credits P2 and P3 Early Experiential


College Dates attended Degree Earned Iowa State University 1966 – 1969 BS in Home Economics

College Dates attended Degree Earned North Dakota State University 1972 – 1974 BS in Pharmacy







H. Publications during past 3 years None

I. Presentations during past 3 years ASHP District Meeting Individual NDPhA District Meeting presentations around the state of North Dakota

J. Present Scholarly Interests and Activities Early Experiential design, development, and outcomes.

K. Present Professional Interests and Activities APhA – ASP ASP Advisor ACCP Fargo West Rotary Club



A. Information

Name: Michael Kelsch Date of Birth: April 4, 1975

Department/Division: Pharmacy Practice Licensed Pharmacist? Yes State: ND, MN, WI





35

Experiential 25 Practice 25 Scholarly activity Committee assignments 10 Student advising 5 Faculty mentoring Administration Other:

Total 100%

Q. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

PHRM 532: Pharmacotherapy of Infectious Diseases PHRM 300: Principles of Clinical Pharmacology (for Nursing program) PHRM 351: Pharmaceutical Care I PHRM 565: PharmacyBased Immunization Delivery


College Dates attended Degree Earned North Dakota State University Fall 1995 – Spring 1999 Pharm.D.




Institution Dates attended Position Pharmacy Practice

Meriter Hospital/University of Wisconsin July 1999 – June 2000 Residency




December 2002: Stroke Prevention during Atrial Fibrillation Pharmacy Newsletter for Heartland Health System, Fargo, ND


November 2004: Northern Plains Ethics Institute: Influenza expert panel discussion at NDSU

August 2003: Drugs of Abuse and Dietary Supplements (ACPE accredited program) Dakota Drug sponsored CE program, Alaska

August 2002: Drugs of Abuse (ACPE accredited program) American Association of Pharmacy Technicians Annual Convention, Fargo, ND

February 2002: Immunization Training Program (ACPE accredited program) MidWinter Pharmacy Seminar, Bismarck, ND


Infectious Diseases, Internal Medicine


Member of, and Faculty Liaison for ASHP and NDSHP



A. Information

Name: Shamima Khan Date of Birth: 05/20/70

Department/Division: Pharmacy Practice Licensed Pharmacist? No

First title at College: Assistant Professor Date appointed: February 2005

Current title: Assistant Professor Date appointed: February 2005


Activity Per cent (%) Teaching: Didactic 40 Experiential 0

Practice 0 Scholarly activity 40 Committee assignments 0 Student advising 10 Faculty mentoring 0 Administration 0 Other: 10

Total 100%

R. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Team teaching as an instructor in the Pharmaceutical Care sequence; preparing to offer one full course in the Spring for Doctor of Pharmacy and Doctor of Nursing students


College Dates attended Degree Earned University of Louisiana at Monroe (ULM) 19911995 B.S.


College Dates attended Degree Earned ULM 19961998; 19982000 M.A. (pursued), MBA

College Dates attended Degree Earned ULM 20002004 Ph.D.




Institution Dates of employment Position University of the Pacific 20032004 Assistant Professor


HoffmannSmith, KA, Khan S, and Lewis SA. An Adverse Drug Phenomenon in Response to Intrathecal Hydromorphone Administration. Accepted for publication at American Journal of Pain Management (IN Press).

I. Presentations during past 3 years (Poster Presentations)

• ‘Pharmacy Student Exposure to Emergency Contraception during Clerkship’ Veronica Bandy, Berit Gundersen and Shamima Khan, University of the Pacific, Thomas J Long School of Pharmacy and Health Sciences, poster was presented at the 2004 AACP Annual Meeting and Seminars Exhibit and Poster Session, July 2004; and the poster was also presented at Non prescriptions Medicines Academy Meeting, September 30 th October 3 rd , 2004

• ‘Improved Asthma Quality of Life in Innercity Schoolchildren Enrolled in an SchoolBased Asthma Education Program’ Mvula M, 1 Moore C, 1 Blake S, 2 Larzalere M, 1 Alexander J, 1 Brenda M, 1 Khan S, 2 and Post R. 1 1Division of Allergy/Immunology, Louisiana State UniversityNew Orleans School of Medicine, 2The University of Louisiana at Monroe School of Pharmacy, poster presented at the Louisiana State University – New Orleans School of Medicine, Summer 2003

• ‘Selected Undergraduate Performance Predictors of SLP Graduate Grade Point Average’ poster presented at the ASHA (American SpeechLanguage and Hearing Association) Convention, November 2002

• ‘Predicting Future HighCost Asthma Patients Based On Past and Current Health Care Service Utilization’ poster presented at the Southern Pharmacy Administration Conference, June 2002


Pharmacoeconomics and Outcomes Assessment, Public Health and Biostatistics, Educational Assessment

K. Present Professional Interests and Activities • Coinvestigator of several Telepharmacy projects • Collaborating with North Dakota Pharmaceutical Association (NDPhA) and North Dakota

Pharmaceutical Care (NDIPC) • Collaborating with local physicians • Coauthoring a book chapter (Insurance and Managed Care)

Current Professional Affiliations: • APhA (American Pharmaceutical Association) 2005 to Present • NDPhA (North Dakota Pharmacists Association) 2005 to Present • AACP (American Association of Colleges of Pharmacy) 2003 to Present



A. Information

Name: Sanku Mallik Date of Birth: 05/09/1968


First title at College: Associate Professor Date appointed: 4/1/06

Current title: Associate Professor Date appointed: 4/1/06



40

Experiential Practice Scholarly activity 50 Committee assignments 10 Student advising Faculty mentoring Administration Other:

Total 100%

S. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences) Will teach Pharmacy Practice


College Dates attended Degree Earned Indian Institute of Technology 08/1984 – 07/1987 BS


College Dates attended Degree Earned Case Western Reserve University 08/1987 – 10/1991 Ph D


Institution Dates attended Position California Institute of Technology 10/1991 – 12/1993 Research Associate

Institution Dates attended Position California Institute of Technology 01/1993 – 12/1993 Senior Research Associate


Institution Dates of employment Position University of Central Florida 08/2005 – current Associate Professor

Institution Dates of employment Position North Dakota State University 07/2002 – 08/2005 Associate Professor

Institution Dates of employment Position North Dakota State University 01/1998 – 06/2002 Assistant Professor


(1) Blocking the accessibility of the active site pocket of matrix metalloproteinase9 by designing multiprong surfacebinding groups. Banerjee, A. L.; Haldar, M. K.; Tolwala, S.; Swanson, M.; Roy, B. C.; Mallik, S.; Srivastava, D. K. J. Chem. Soc. Chem. Commun. 2005, 25492551.

(2) Synthesis of polymerizable lipids to sensitize Dy 3+ and protein detection. Haldar, M. K.; Santos, M.; Rex, M.; Mallik, S.; Campiglia, A. D. Bioconjugate Chem., in press.

(3) Design of photocleavable lipids and their applications in liposomal “uncorking”. Chandra, B.; Mallik, S.; Srivastava, D. K. J. Chem. Soc. Chem. Commun. 2005, 30213023.

(4) Optimization of conditions for flowthrough partialfilling affinity capillary electrophoresis to estimate binding constants of ligands to receptors. Brown, A.; Desharnais, R.; Roy, B.C.; Malik, S; Gomez, F. A. Anal. Chim. Acta 2005, 540, 403410.

(5) Spacer based selectivity in the binding of “twoprong” ligands to recombinant human carbonic anhydraseI. Banerjee, A. L.; Eiler, D.; Roy, B. C.; Jia, X.; Haldar, M. K.; Mallik, S.; Srivastava, D. K. Biochemistry 2005, 44, 32113224.

(6) Solidphase synthesis of polymerizable, lanthanide chelating lipids for protein detection. Nadi, S.; Santos, M.; Haldar, M. K.; Roy, B. C.; Mallik, S.; Campiglia, A. D. Inorganic Chemistry 2005, 44, 22342244.

(7) Evaluation of two lanthanide complexes for qualitative and quantitative analysis of target proteins via partial least squares analysis. Goicoechea, H.; Roy, B. C.; Santos, M.; Campiglia, A. D.; Mallik, S. Anal. Biochem.2005, 336, 6474.

(8) Triggered release of liposomal contents by matrix metalloproteinase9. Sarkar, N. R.; Rosendahl, T.; Krueger, A. B.; Banerjee, A. L.; Mallik, S.; Srivastava, D. K. J. Chem. Soc. Chem. Commun. 2005, 9991001.

(9) Molecular basis for the origin of differential spectral and binding profiles of dansylamide with human carbonic anhydrase I and II. Banerjee, A. L.; Tobwala, S.; Srivastava, D. K.; Mallik, S. Biochemistry 2005, 44, 36733682.

(10) Twoprong inhibitors for human carbonic anhydrase II. Roy, B. C.; Banerjee, A. L.; Kloche, D. L.; Swanson, M.; Jia, X.; Haldar, M. K.; Mallik, S.; Srivastava, D. K. J. Am. Chem. Soc. 2004, 126, 1320613207.

(11) Purification of recombinant human carbonic anhydraseII without incorporating histidine tags. Banerjee, A. L.; Swanswon, M.; Mallik, S.; Srivastava, D. K. Protein Expr. Purif. 2004, 37, 450 454.

(12) Protein surfaceassisted enhancement of the binding affinity of an inhibitor for recombinant human carbonic anhydraseII. Banerjee, A. L.; Swanson, M.; Roy, B. C.; Jia, X.; Haldar, M. K.; Mallik, S.; Srivastava, D. K. J. Am. Chem. Soc., 2004, 126, 1087510883.

(13) An investigation on the analytical potential of polymerized liposomes bound to lanthanide ions for protein analysis. Santos, M.; Roy, B. C.; Goicoechea, H.; Campiglia, A. D.; Mallik, S. J. Am. Chem. Soc., 2004, 126, 1073810745.

(14) Conjugation of surface binding groups to poor inhibitors: a strategy to improve inhibitor efficiency. Roy, B. C.; Rodendahl, T.; Hegge, R.; Peterson, R.; Mallik, S.; Srivastava, D. K. J. Chem. Soc. Chem. Commun., 2003, 2328 – 2329.

(15) Synthesis of metalchelating lipids to sensitize lanthanide ions. Roy, B. C.; Santos, M.; Mallik, S.; Campiglia, A. D. J. Org. Chem. 2003, 68, 3999 – 4007.

(16) Synthesis of new, pyrenecontaining, metalchelating lipids and sensing of cupric ions. Roy, B. C.; Chandra, B.; Hromas, D.; Mallik, S. Org. Lett. 2003, 5, 1114.


(1) Tirggered release of liposomal contents by MMP9. American Chemical Society National Meeting, Washington, DC August 2005, invited, presenter.

(2) Templated liposomes for selective detection of carbonic anhydrase. PacifiChem Conference, Honolulu, 2005, invited (to be presented).

(3) Twoprong inhibitors for human carbonic anhydrase II. American Chemical Society National Meeting, Philadelphia, August 2004, presenter.

(4) Enhancement of binding affinity of enzyme inhibitors by surface binding groups. Presented at the Molecular Recognition Symposium, Salt Lake City, January 2004, invited presenter.

(5) Synthesis of lanthanidechelating lipids and use of lifetimes to detect proteins. American Chemical Society National Meeting, New York, August 2003, presenter.

(6) Strategies of targeting MMPs employing hybrid liposomes. MMP symposium, Fargo, May 2003, presenter.

(7) Synthesis of polymerizable metalchelating lipids as membrane probes. American Chemical Society National Meeting, Boston, August 2002, presenter.


Design of isozymeselective inhibitors for carbonic anhydrase XII, matrix metalloproteinase2 and –9, liposomal delivery of the inhibitors, triggered release of liposomal contents by enzymes and by light.


Member, American Chemical Society

Journal Referee: Journal of the American Chemical Society, Journal of Organic Chemistry, Organic Letters, Langmuir.

Proposal Reviewer: National Science Foundation (mail reviewer), National Institutes of Health (mail reviewer).



A. Information

Name: Donald Miller Date of Birth: 11/15/1954

Department/Division: Pharmacy Practice Licensed Pharmacist? Yes: State: ND

First title at College: Lecturer Date appointed: August 1978

Current title: Professor Date appointed: July 1998



35


Total 100%

T. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Phrm 480: Drug Literature Evaluation, 3 credits Phrm 534: Pharmacotherapy of Rheumatology, half of a 2 credit course Phrm 351: Pharm Care I, 3 lectures APE rotation: Academic Rotation, 5 students


College Dates attended Degree Earned University of Manitoba 197276 B.S. Pharmacy

College Dates attended Degree Earned University of Michigan 197678 Pharm.D.




Institution Dates attended Position University of Saskatchewan Hospital 197778 Residency in Hospital Pharmacy




Aboezz R, Miller DR. Accuracy of portable blood glucose monitors. J Am Pharm Assoc. 2005;45(4):514516.

Miller DR. Clinical Twister Risks of COX2 vs. NSAID? Drug Topics (HealthSystem edition) 2004;148(22):HSE8.

Miller DR and Sleckman J. Editorial Consultants. Fibromyalgia and Fibromylagia/alternative and complementary medicine modules in: Physicians Information and Education Network (PIER). American College of Physicians. Online: http://pier.acponline.org/index.html 200405

Miller DR. An assessment of critical thinking: Can pharmacy students evaluate clinical studies like experts? Am J Pharm Educ 2004;68:article 5, Online: http://www.ajpe.org/aj6801/aj680105/aj680105.pdf

Miller DR. Pharmacotherapy for Musculoskeletal Disorders: Osteoarthritis, rheumatoid arthritis, gout, foot problems. Online review modules for GeriatricPharmacyReview.Com (online at http://www.geriatricpharmacyreview.com). American Society of Consultant Pharmacists 2004.

Hagen J, Gott N, Miller DR. Reliability of saliva hormone tests. J Am Pharm Assoc 2003;43:724 6.

Miller DR. Longitudinal assessment of critical thinking skill in pharmacy students. Am J Pharm Educ 2003;67:8907. (Online: 2003;article 120, http://www.ajpe.org/aj6704/aj6704120/aj6704120.pdf)


AUpdate on Arthritis Therapy@. ND Pharmacists Association Annual April 2005 Meeting, Jamestown, ND.

AEffective Treatment of Arthritis@, ND Nurses Association 8th Annual Nov 2004 Pharmacology Seminar, Fargo

AFibromyalgia Syndrome@, Dakota Drug Gift Show, Fargo July 2004

AChronic Fatigue Syndrome and Other Functional Somatic Syndromes@ Feb 2004 ND Midwinter Pharmacy Seminar, Bismarck, ND

ATreatment of Osteoporosis@, ND Nurses Association 7th Annual Nov 2003 Pharmacology Seminar, Bismarck

AMedication Update@, CARE Conference for arthritis patients. Oct 2003 Brooklyn Park, MN

AMedications for Arthritis@, Nursing Continuing Education Apr 2003 Conference, Mankato, MN

AUpdate on Osteoporosis@, ND Midwinter Pharmacy Seminar Feb 2003 Bismarck, ND


Assessment of critical thinking in pharmacy students Assessment of curricular outcomes in pharmacy


Treatment of rheumatic conditions

Arthritis Foundation, North Central Chapter, Board of Directors 2001 (Chair, Research Grants Subcommittee 2001) (Chair, Medical and Scientific Committee 200204)



A. Information

Name: Cynthia A. Naughton Date of Birth: 11/20/55

Department/Division: Pharmacy Practice Licensed Pharmacist? Yes State: ND & MN

First title at College: Adjunct Clinical Professor Date appointed: 7/1998

Current title: Assistant Professor Date appointed: 7/2000



Practice 40 Scholarly activity 4 Committee assignments 5 Student advising 1 Faculty mentoring 0 Administration 0 Other:

Total 100%

U. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Pharmacy 537: Renal, Fluid & Electrolytes (course coordinator) Pharmacy 351: Pharmaceutical Care (P1 Mentor) Pharmacy 352: Pharmaceutical Care (P1 Mentor) University Studies 189: Skills For Academic Success (2 sections)


College Dates attended Degree Earned Bemidji State College 1973 1974


North Dakota State University 1974 – 1978 BS Pharmacy


College Dates attended Degree Earned North Dakota State University 1986 M.S. Pharmacy

College Dates attended Degree Earned North Dakota State University 1995 Pharmacy Doctorate


November 1999 Nephrology Traineeship Hennepin County Medical Center Minneapolis, Minnesota

April 1999 Anticoagulation Service Traineeship ASHP Research & Education Foundation James Haley Veterans Medical Center Tampa, Florida

May 1997 Nephrology Pharmaceutical Care Preceptorship University of Pittsburgh Medical Center Pittsburgh, Pennsylvania



H. Publications during past 3 years Naughton CA. Chronic kidney disease: Early detection and treatment. US Pharm 2004;11:HS27 HS33.

Brown W, Naughton C, Henderson M, Espejo L. Improving patient’s awareness of asthma symptoms. Poster presentation. National Asthma Educator Conference, Philadelphia. June 2004

Naughton CA, Duppong LM, Forbes KD, Sehgal I. Stability of multidose, preserved formulation epoetin alfa in syringes for three and six weeks. Am J HealthSyst. Pharm. 2003;60:4648.

Naughton CA. Establishing pharmaceutical services on a renal dialysis unit. Am J HealthSyst Pharm 2002;59:21112.

I. Presentations during past 3 years Pharmacy Career Alternatives Panel. APhAASP Midyear Regional Meeting.

Moorhead, Minn. October 2004.

Professionalism in the Workplace. National Association of Pharmacy Technician Fall Conference. Fargo, ND. September 2004.

Management of CKD in the Primary Care Setting. NDSU Pharmacy Midwinter CE. Bismarck, ND. February 2004

Chronic Kidney Disease. Family HealthCare Center Providers. Fargo, ND. October 2003

Herbal Supplements. Presentation Sisters Convent. Fargo, ND. May 2003

Herbal Supplements. Sts. Anne & Joachim Health Fair. Sts. Anne & Joachim Church, Fargo, ND. March 2003

Your Cardiovascular Health. Family HealthCare Center Patient Outreach. Fargo, ND. February 2003

Managing the Deadly Duo. National Association of Pharmacy Technician Annual Meeting. Fargo, ND. August 2002

Fluid and Electrolytes 101. North Dakota Midwinter Pharmacy Seminar. Bismarck, ND. February 2002


Principal Investigator: Effectiveness of Pharmacist Interventions on Controlling Modifiable Risk Factors for Chronic Kidney Disease in High Risk Patients Compared to Usual Medical Care


American Association of Colleges of Pharmacy (2004 Delegate) American College of Clinical Pharmacy North Dakota Pharmaceutical Association



A. Information

Name: Kenton Thomas Omvig Date of Birth: 11211965


First title at College: Assistant Professor Date appointed: 811993

Current title: Assistant Professor Date appointed: 811993



10


Total 100%

V. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Gerontology NonPrescription Medications Adult Medicine Experiential


College Dates attended Degree Earned North Dakota State University 19841989 B.S. Pharmacy

College Dates attended Degree Earned North Dakota State University 19911993 Pharm.D.








1. Comparison of Two Methods for Estimating Glomerular Filtration Rate. Poster: ASHP Midyear meeting December, 2003


1. Cardiovascular Disease University of Mary March 2005 Bismarck, ND

2. Parkinson’s Disease, Spinal Cord Injury, Head Injury University of Mary March 2005 Bismarck, ND

3. Geriatric Pharmacology: Principles of Aging University of Mary February 2005 Bismarck, ND

4. Medications for Dementia and Depression; Geriatric Healthcare, Alzheimer’s & Hospice Conf. October 2004 Bismarck, ND

5. Geriatric Pharmacology: Principles of Aging University of Mary March 2004 Bismarck, ND

6. Orthostatic Hypotension University of Mary November 2003 Bismarck, ND

7. Parkinson’s Disease, Spinal Cord Injury, Head Injury University of Mary November 2003 Bismarck, ND


Dakota Geriatric Education Center grant: Development of geriatric curricular enhancements, Geriatric pharmacist residency program and drug therapy management program


Dakota Geriatric Education Center grant: Development of geriatric curricular enhancements, Geriatric pharmacist residency program and drug therapy management program



A. Information

Name: Stephen T. O’Rourke Date of Birth: 11/6/55



Current title: Associate Professor Date appointed: 1996



45


Total 100%

W. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Pharm Sci 414 Pharm Sci 790


College Dates attended Degree Earned University of Wisconsin 197379 BS


College Dates attended Degree Earned University of Wisconsin 198183 MS

College Dates attended Degree Earned University of Wisconsin 198385 PhD


Institution Dates attended Position Mayo Clinic 198587 Postdoctoral Fellow


Institution Dates of employment Position Medical College of Wisconsin 198890 Assistant Professor


O'Rourke, S.T.: Nitrovasodilators: Pharmacology and use in the treatment of myocardial ischemia. American Journal of Pharmaceutical Education 66: 177180, 2002.

O'Rourke, S.T., Hammad, H., Delagrange, P., Scalbert, E., and Vanhoutte. P.M.: Melatonin inhibits nitrate tolerance in isolated coronary arteries. British Journal of Pharmacology 139: 132632, 2003.

O'Rourke, S.T., Vanhoutte, P.M., and Miller, V.M.: Biology of Blood Vessels: Vascular Pharmacology. In:Vascular Medicine (3rd edition), ed. by J. Loscalzo, M.A. Creager, and V.J. Dzau; Little, Brown and Company (in press).

Ghatta, S., Nimmagadda, D., Xu, X., and O’Rourke, S.T.: Largeconductance, calciumactivated potassium channels: A structural and functional overview. Pharmacology and Therapeutics (in review).

Ghatta, S. and O’Rourke, S.T.: Role of endogenous calcitonin generelated peptide in the development of nitrate tolerance. Cardiovascular Research (in review)


Role of K channels in nitroglycerininduced vasorelaxation: Functional implications for nitrate tolerance. Presented at Experimental Biology ’03, San Diego, CA, April 1115, 2003.

Role of K channels in nitroglycerininduced relaxation of nitrate tolerant blood vessels. Presented at AURA Summer Research Poster Session, Grand Forks, ND, August 4, 2003.

Role of endogenous CGRP in the development of nitrate tolerance. Presented at Experimental Biology 2004, Washington, DC, April 1721, 2004.

BKCa Status in Nitrate Tolerance. Presented at the 2004 Engebretson Symposium, Fargo, ND, May 11, 2004.

Role of Endogenous CGRP in the Development of Nitrate Tolerance. Presented at the 2004 Engebretson Symposium, Fargo, ND, May 11, 2004.

Nitroglycerin Increases BKCa Activity in Vascular Smooth Muscle and HEK293 Cells. Presented at the 2004 Engebretson Symposium, Fargo, ND, May 11, 2004.

Superoxides partly mediate the development of nitrate tolerance in rat aorta. Presented at EPSCoR Undergraduate Research Poster Session, Fargo, ND, August 3, 2004.

Effects of rapamycin on human radial artery responses. Presented at American College of Physicians, Fargo, ND, September 24, 2004.

Sirolimus causes endotheliumindependent relaxation of isolated human arteries. Presented at American Heart Association Scientific Sessions, New Orleans, LA, November 710, 2004.

Hydrogen peroxide inhibits nitrate tolerance in isolated rat aorta. Presented at Experimental Biology, San Diego, CA, April 26, 2005.

Effects of sirolimus on human radial arteries. Presented at Engebretson Symposium on Drug Development, Minneapolis, MN, June 8, 2005.

Role of hydrogen peroxide in nitrate tolerance. Presented at Engebretson Symposium on Drug Development, Minneapolis, MN, June 8, 2005.

Role of hydrogen peroxide in nitrate tolerance development. Accepted for presentation at AAPS Annual Meeting, Nashville, TN, November 610, 2005.


Cardiovascular pharmacology


Cardiovascular pharmacology



A. Information

Name: Lawrence A. Patnaude Jr. Date of Birth: 121268



Current title: Assistant Professor Date appointed: 10105


Activity Per cent (%) Teaching: Didactic Experiential 65

Practice Scholarly activity 10 Committee assignments Student advising 25 Faculty mentoring Administration Other:

Total 100%

X. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Responsible for instruction in the Concept Pharmacy Lab, Phrm 351, 352, 451, 452, 551, 552


College Dates attended Degree Earned North Dakota State University 1995 – 2001 Pharm.D







H. Publications during past 3 years – None


Northern Plains Heart and Diabetes Conference 2004 and 2005 (Medication Management, Osteoarthritis)

Native American Wisdom Steps Annual Conference 2003 and 2004 (Diabetes, Hypertension)

Several presentations to Native American Elders 20022005(approximately 6 per year) covering the topics of diabetes, osteoarthritis, hypertension, Parkinson’s Disease, ADHD, medication management, vitamins and minerals


Pharmaceutical Care, Patient Consultation and Physical Assessment, Diabetes Research.

K. Present Professional Interests and Activities – ASHP student Clinical Competition, APhA



A. Information

Name: Charles D. Peterson Date of Birth: 11/21/52

Department/Division: Pharmacy Practice Licensed Pharmacist? Yes State: ND, MN

First title at College: Associate Dean & Chair Pharmacy Practice Date appointed: May 1, 1989

Current title: Dean of the College of Pharmacy Date appointed: July 1, 1995


Activity Per cent (%) Teaching: Didactic Experiential

Practice Scholarly activity 5% Committee assignments Student advising Faculty mentoring Administration 95% Other:

Total 100%

Y. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)


College Dates attended Degree Earned College of Pharmacy University of Minnesota 9/73 – 5/76 BS in Pharmacy

College Dates attended Degree Earned College of Pharmacy University of Minnesota 9/75 – 5/77 Pharm.D.




Institution Dates attended Position College of Pharmacy University of Minnesota 7/1/78 – 6/30/78 Fellowship in Toxicology


Institution Dates of employment Position College of Pharmacy 19781989 Associate Professor University of Minnesota Pharmacy Practice


Peterson CD and Anderson HC. Chapter Ten: Telepharmacy. In Telemedicine Technical Assistance Document: A Guide to Getting Started in Telemedicine. Edited by Joseph Tracy and Dena Puskin, Office for the Advancement of Telehealth, Division of Health Resources and Services Administration of Health and Human Services, pp. 206240, copyright 2004.

Peterson CD and Anderson HC. The North Dakota Telepharmacy Project: Restoring and Retaining Pharmacy Services in Rural Communities. The Journal of Pharmacy Technology 2004; 20: 2839.


Peterson CD. Alternative Practice Models: North Dakota Experience with Telepharmacy for Rural North Dakota. 68 th Annual District V Meeting of National Association of Boards of Pharmacy and American Association of Colleges of Pharmacy, Minneapolis, Minnesota, August 1113, 2005.

Peterson, CD, Scott, D. Rathke A. The North Dakota Telepharmacy Project, Upper Great Plains Technology Showcase, Fargodome, Fargo, North Dakota, October 11, 2004.

Peterson CD, Pharmacy Technicians: Future Roles and Responsibilities. Northland Association of Pharmacy Technicians Annual Meeting, Fargo, North Dakota, September 24, 2004.

Peterson CD and Sprafka S. The North Dakota Telepharmacy Project, Merit/Internet 2 Networking for Michigan’s Future, Event for Michigan Legislators, Lansing, Michigan, June 1, 2004.

Peterson CD and Sprafka S. The North Dakota Telepharmacy Project. SURA/ViDe 6 th Annual Digital Video Workshop, Indianapolis, Indiana, March 23, 2004

Peterson, CD. The North Dakota Telepharmacy Project, Upper Great Plains Technology Showcase, Fargodome, Fargo, North Dakota, October 14, 2003.

Peterson, CD. The North Dakota Telepharmacy Project, South Dakota Pharmacist Association and the South Dakota State Board of Pharmacy combined meeting, March 12, 2003.

Peterson, CD. The North Dakota Telepharmacy Project, North Dakota Higher Education Showcase at the State Capitol, North Dakota Legislative Assembly, Bismarck, North Dakota, February 4, 2003.

Peterson, CD and Anderson, HC.. The North Dakota Telepharmacy Project, 2003 Marketplace Ideas Conference, Alerus Center, Grand Forks, North Dakota, January 16, 2003.


Exploring Alternative Practice Models for delivering pharmacy services in medically underserved remote rural communities via telepharmacy.


Professional Interests: Developing the College, its people, and programs as a center of excellence in pharmaceutical education and research and procuring the necessary human and financial resources to ensure the highest quality program possible.

Professional Activities

20042005 Chair, NDSU Search Committee for Dean of Engineering and Architecture

20042005 Member, University Advisory Committee on Alcohol and Other Drugs

2004 Evaluation Team Member For Accrediting Colleges of Pharmacy, American Council on Pharmaceutical Education (ACPE), Evaluation of Ferris State University College of Pharmacy, Big Rapids, Michigan (October 2004)

2004Present Member, Board of Directors, NDSU Research Foundation.

2003Present Faculty Advisor, Christian Pharmacist Fellowship International

20032004 Member, Provost’s Computer Use Policy Ad Hoc Committee

20022003 Chair, NDSU Search Committee for Director of Information Technology

2001Present Member, President’s Diversity Council

2000 Evaluation Team Member For Accrediting Colleges of Pharmacy, American Council on Pharmaceutical Education (ACPE), Evaluation of the University of Montana, Missoula, Montana (April 2000)

1999Present Member, President’s Council, North Dakota State University

1999Present Faculty Advisor, Intervarsity Christian Fellowship

1998Present Team Pharmacist, NDSU Bison Athletics Program



A. Information

Name: Steven (Yue) Qian Date of Birth: 09201960


First title at College: Assistant Professor Date appointed: December 2005

Current title: Assistant Professor Date appointed: December 2005



0

Experiential 40 Practice 0 Scholarly activity 25 Committee assignments 0 Student advising 5 Faculty mentoring 5 Administration 0 Other: 25

Total 100%

Z. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

No teaching responsibility for my first year at NDSU


College Dates attended Degree Earned Nanjing University 19781982 B.S.


College Dates attended Degree Earned University of Iowa 19941996 M.S.

College Dates attended Degree Earned University of Iowa 19961999 Ph.D.


Institution Dates attended Position NIEHS, NIH 20002004 Postdoc


Institution Dates of employment Position University of North Carolina 20042005 Assistant Professor

Institution Dates of employment Position Nanjing University 19821994 Chemist/Lecturer

H. Publications during past 3 years Qian, SY; Kadiiska, MB; Guo, Q; Liu, J; and Mason, RP. Free Radic. Biol. Med. 38: 125135; 2005.

Guo, Q, Gao, G, Qian, SY, and Mason, RP.. Chem. Res. Toxicol. 17: 14811490; 2004.

Colon, ML; Qian, SY; Vanderveer, D; and Bu, XR. Inorg. Chim. Acta. 357: 8388; 2004.

Towner, RA; Qian, SY; Kadiiska, MB; and Mason, RP. Free Radic. Biol. Med. 35: 13301340; 2003.

Qian, SY; Guo, Q; and Mason, RP. Free Radic. Biol. Med. 35: 3344; 2003

Guo, Q; Qian, SY; and Mason, RP. 14: 862871; 2003.

Qian, SY.; Yue, GH.; Tomer, KB.; and Mason, RP. Free Radic. Biol. Med. 34: 10171028; 2003

I. Presentations during past 3 years (for published only)

Qian, SY; Kadiiska, MB; Mason, RP. Free Radic. Biol. Med. 35(S1); 21, 2003. SFRBM’s 10 th annual meeting

Towner, R; Qian, SY; Kadiiska, MB; Mason, RP. Free Radic. Biol. Med. 35(S1): 29; 2003. SFRBM’s 10 th annual meeting

Qian, SY; Ren, HH; Mason, RP. 11th In vivo EPR spectroscopy/ imaging and 8 th International EPR Spin Trapping Meeting (Columbus, Ohio, September 2005)

J. Present Scholarly Interests and Activities Apply for research grants, such as NIH R21 and R01, and write research papers


Interests: Free radical chemistry and biology as related to problems of human health; Iron and oxygen chemistry as related to the initiation of biological, free radical oxidations; Oxidative stress and xenobiotic disposition as related to pathogenesis of organ disease processes; Free radicals in toxicology and pharmacology.

Activities: attend scientific meetings, write research papers, and apply for research grants



A. Information

Name: Tara Schmitz Date of Birth: 02/27/1971

Department/Division: Pharmacy Practice Licensed Pharmacist? Yes State: ND/MN

First title at College: Lecturer Date appointed: 1/1/2001

Current title: Assistant Professor, Continuing Education Administrator Date appointed: 7/1/2003



47

Experiential Practice 20 Scholarly activity 1 Committee assignments 1 Student advising 1 Faculty mentoring Administration 30 Other:

Total 100%

AA. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Teaching responsibilities are currently changing due to job description change. Courses currently teaching include Pharmaceutical Care 352 OTC Recommendations, Pharmaceutical Care 451 Intro to Consultation and Law, and DUR Review, Pharmaceutical Care 551 Consultation, and Dermatology, Pharmaceutical Care 552 Medication Therapy Management, and Stress Management for Health Care Professionals. Last year I was team teaching in the Concept Pharmacy Laboratory, but this year will only be teaching in the lab occasionally. Job Description change effective July 2005 shifts teaching responsibilities to more experiential at an Adult Medicine Site in rural ND.


College Dates attended Degree Earned NDSU College of Pharmacy 19911995 Pharm.D.







H. Publications during past 3 years None


Phi Lambda Sigma Leadership Organization Orientation presentations 1. Attitudes of a Leader 2. Characteristics to keep you from hearing “You’re Fired!” 3. Leading by example 4. Characteristics of a LEADER

Faculty Development Day, “Issues related to Women’s Health”


CoInvestigator for Geriatric Education Centers Grant

Interest in development of Medication Therapy Management Program through Continuing Education programs and its impact in the elderly population


Pharmat Committee for Educational Needs Assessment and Evaluation Field Reviewer for ACPE Pharmat Advisory Board College of Pharmacy Admissions Committee Concept Pharmacy planning work group Advisor for Phi Lambda Sigma Member of North Dakota Pharmacist’s Association Member of American Association of Colleges of Pharmacy



A. Information

Name: David M. Scott, MPH, PhD Date of Birth: 7549

Department/Division: Pharmacy Practice Licensed Pharmacist? Yes State: MN

First title at College: Associate Professor Date appointed: 8103

Current title: Associate Professor Date appointed: 8103



40

Experiential Practice Scholarly activity 30 Committee assignments 15 Student advising 5 Faculty mentoring 10 Administration Other:

Total 100%

BB. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Pharmaceutical Care I (351) Pharmaceutical Care II (352) Pharmacy Practice Management (475)


College Dates attended Degree Earned University of Minnesota 196772 BS in Pharmacy


College Dates attended Degree Earned Health Education and Interdisciplinary Studies Program, School of Public Health, University of Minnesota 1979 – 1982 M.P.H.

College Dates attended Degree Earned Social and Administrative Pharmacy Program, University of Minnesota 1982 1987 Ph.D.


Institution Dates attended Position Harvard School of Public Health, course on costeffectiveness analysis for medical technologies and pharmaceuticals. 1998 postdoctoral training

Institution Dates attended Position University of Michigan Graduate Summer Session in Epidemiology, 8 courses on epidemiology, methods, and statistics. 19921994 postdoctoral training


Pharmacy Administration, Department of Pharmacy Practice, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 1996 2003 Associate Professor

Pharmacy Administration, Department of Pharmacy Practice, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 1986 1996 Assistant Professor


Peer reviewed publications Faldmo D, Stephan M, Boyd ST, Scott DM: Dietary Cactus Reduces Glucose Levels in a Hispanic Man: Case Report. J. American Academy of Physician Assistants. 2004:17:3536.

Scott DM, Robinson DH, Augustine SC, Roche EB, Ueda CT: Development of a Professional Pharmacy Outcomes Assessment Plan Based on Student Abilities and Competencies. American J. Pharmaceutical Education, 2003; 66: 357364.

Scott DM, Friedli D: Attendance Problems and Disciplinary Procedures in Nebraska Schools. Journal of Drug Education, 2002: 32: 149165.

Book chapters Scott DM: Overview of Health and Health Care in the United States. In: Wertheimer AI and Smith MI (editors). Pharmacy and the U.S. Health Care System, 3rd edition, Pharmaceutical Products Press. New York, NY, 2005 (In Press).

Scott DM, Lubotsky BL, Hanson A: Informatics in Health Care. In: McCarthy RL and Schafermeyer KW (editors). Chapter 13, Introduction to Health Care Delivery: A Primer for Pharmacists, Online Instructors Manual, Jones and Bartlett Publishers, Sudbury, MA, 2004.

Scott DM: Ambulatory Care. In: McCarthy RL (editor). Introduction to Health Care Delivery: A Primer for Pharmacists, Online Instructors Manual, Chapter 4, Jones and Bartlett Publishers, Sudbury, MA, 2004.

Scott DM, Lubotsky Levin B, Hanson A: Informatics in Health Care. In: McCarthy RL and Schafermeyer KW (editors). Chapter 13, Introduction to Health Care Delivery: A Primer for Pharmacists, 3rd edition, Jones and Bartlett Publishers, Sudbury, MA, 377404, 2004.

Scott DM: Ambulatory Care. In: McCarthy RL and Schafermeyer KW (editors). Chapter 4, Introduction to Health Care Delivery: A Primer for Pharmacists, 3rd edition, Jones and Bartlett Publishers, Sudbury, MA, 257288, 2004.


Platform presentations

Scott DM, Rathke A: Medication Dispensing Error Study of North Dakota Telepharmacy Sites. USDHHS, HRSA Office for the Advancement of Telehealth (OAT) Grantees Annual Meeting, Breakout Session, January 31, 2005, Arlington, Virginia.

Scott DM: Research in North Dakota: Upper Midwest Consortium for Clinical Research. Upper Midwest Consortium for Clinical Research, School of Public Health, University of Minnesota, November 23, 2004, Minneapolis, Minnesota.

Scott DM: Randomized Trial Comparing Pharmacist Diabetes Education and Standard Care at the Siouxland Community Health Center. College of Pharmacy, Auburn University, May 15, 2003, Auburn, Alabama.

Scott DM: Randomized Trial Comparing Pharmacist Diabetes Education and Standard Care at the Siouxland Community Health Center. College of Pharmacy, Nova Southeastern University, April 28, 2003, Fort Lauderdale, Florida.

Scott DM: Randomized Trial Comparing Pharmacist Diabetes Education and Standard Care at the Siouxland Community Health Center. School of Pharmacy and Pharmacal Sciences, Purdue University, March 24, 2003, West Lafayette, Indiana.

Scott DM: Randomized Trial Comparing Pharmacist Diabetes Education and Standard Care at the Siouxland Community Health Center. College of Pharmacy, North Dakota State University, March 10, 2003, Fargo, North Dakota.

Scott DM: Randomized Trial Comparing Pharmacist Diabetes Education and Standard Care at a Community Health Center. College of Pharmacy, University of Minnesota, February 20, 2003, Minneapolis, Minnesota.

Poster presentations

Scott DM, Anderson, H, Peterson C, Rathke A: Medication Error Study of North Dakota Telepharmacy Sites. American Pharmacists Association Annual Meeting, Poster Session, April 24, 2005, Orlando.

Scott DM, Boyd, SC, Stephans M, Augustine SC, Himmler B: Randomized Trial Comparing a Clinical Pharmacist as a Diabetes Lifestyle Coach to Standard of Care at the Siouxland Community Health Center (SCHC). American Diabetes Association 63rd Scientific Sessions, Poster Session, June 1417, 2003, New Orleans.

Scott DM, Boyd, SC, Augustine SC, Rouse R, Himmler B, Stephans M: Assessment of a Diabetes Disease State Management Program at the Siouxland Community Health Center (SCHC). APhA Annual Meeting, Poster Session, March 17, 2002, Philadelphia.


Areas of interest: rural health, drug policy, pharmaceutical care

North Dakota Telepharmacy Project – research studies include: Medication dispensing errors study Pharmaceutical Care Survey of North Dakota Pharmacists Consumer satisfaction survey


Member of APhA, North Dakota Pharmacists Association, and AACP Areas of interests: Practice based changes in pharmaceutical care, workforce issues, rural health

Activities include: North Dakota Institute for Pharmaceutical Care North Dakota Telepharmacy Project



A. Information

Name: Jonathan Sheng Date of Birth: 11/20/59






40


Total 100%

CC. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

PSCI 412, Course coordinator and coinstructor, 24 hours/per year. PSCI 411, Course coordinator and coinstructor, 15 hours/per year PSCI 416, coinstructor, 11 hours/per year. BIOC796, coinstructor, 2 hours/per year.


College Dates attended Degree Earned Kunming Medical College Aug 1979 Bachelors of Medicine


College Dates attended Degree Earned State University of New York at Albany, Aug 1994 PhD


Institution Dates attended Position University of Iowa Aug 1998 PostDoc fellow




1. Sheng, J. J., and Duffel, M. W. (2003) Enantioselectivity of human hydroxysteroid (alcohol) sulfotransferase ST2A3 (SULT2A1) for 1naphthyl1ethanol, a model 1arylethanol. Drug Metabolism and Disposition. 31:697700.

2. Sheng, J. J., Saxena, A., and Duffel, M. W. (2004) Influence of phenylalanines 77 and 138 on the stereospecificity of aryl sulfotransferase IV. Drug Metabolism and Disposition. 32:559 565.


1. Greiff, A.H. and Sheng, J.J. Quantitative analysis of gene expression of hydroxysteroid/ alcohol sulfotransferase (SULT2A1) and estrogen sulfotransferase (SULT1E1) in normal and malignant human prostate cell lines. Experimental Biology 2004/ American Society for Pharmacology and Experimental Therapeutics, Washington DC, (2004), Poster presentation

2. Sheng, J.J. Hydroxysteroid/alcohol metabolism by human sulfotransferase SULT2A1, 96th Annual Meeting of the North Dakota Academy of Sciences, Fargo, ND, (2004), Oral presentation.

3. Nimmagadda, D. and Sheng, J.J. Rat hepatic 3’phosphoadenosine5’phosphosulfate (PAPS) synthetase: activity assay development and gene expression quantitation. Engebretson Symposium 2004, Fargo, ND, (2004), Poster presentation.

4. Nimmagadda, D., Greiff, A., Gustad, T., and Sheng, J. Overexpression of hydroxysteroid sulfotransferase SULT2A1 enhances the cytotoxicity of Nhydroxy2 acetylaminofluorene in human embryonic kidney 293 cells Experimental Biology 2005/ American Society for Pharmacology and Experimental Therapeutics, San Diego, CA, (2005), Poster presentation.

5. Nimmagadda, D. and Sheng, J.J. Involvement of human hydroxysteroid sulfotransferase SULT2A1 in Nhydroxy2acetylaminofluorene induced cytotoxicity in human embryonic kidney 293 cells. Engebretson Symposium 2005, Minninapolis, MN, (2005), Poster presentation.


My current research work is focusing on (1) structure, function and cell biology of cytosolic sulfotransferases; (2) the roles of cytosolic sulfotransferases in carcinogenesis; (3) molecular mechanisms of steroid actions; (4) Drug and xenobiotic metabolisms.


N/D



A. Information

Name: Jagdish Singh Date of Birth: 1261953



Current title: Professor and Chair Date appointed: 1112002



30

Experiential Practice Scholarly activity 40 Committee assignments Student advising Faculty mentoring Administration 30 Other:

Total 100%

DD. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

PSCI 369 (Pharmaceutics II) Dosage Forms and Drug Delivery Systems 3 credits


College Dates attended Degree Earned BHU Institute of Technology July 1973June 1977 BS (Pharmacy)


College Dates attended Degree Earned BHU Institute of Technology July 1977June 1979 MS (Pharmaceutics)

College Dates attended Degree Earned BHU Institute of Technology July 1979June 1982 Ph.D. (Pharmaceutics)


Institution Dates attended Position University of Otago, NZ July 1985June 1988 Postdoctoral Fellow

Institution Dates attended Position University of California, San Francisco Dec. 1992August 1994 Postdoctoral Fellow


Institution Dates of employment Position BHU Institute of Technology July 1979June 1988 Assistant Professor

Institution Dates of employment Position BHU Institute of Technology July 1988November 1992 Associate Professor


1. S Chen, R. Pieper, DC Webster and J Singh, Triblock copolymers: Synthesis, characterization, and delivery of a model protein. International Journal of Pharmaceutics, 288 (2), 207218, 2005.

2. Summet K. Rastogi and Jagdish Singh, Effect of chemical penetration enhancer and iontophoresis on the in vitro percutaneous absorption enhancement of insulin through porcine epidermis. Pharmaceutical Development and Technology, 1, 97104, 2005.

3. Babu Medi and Jagdish Singh, In Vivo NonViral Cutaneous Gene Delivery using Electroporation. International Journal of Pharmaceutics, 294, 5363, 2005.

4. S Chen and J Singh, Controlled release of testosterone from smart polymer solution based systems: In vitro evaluation. International Journal of Pharmaceutics, 295 (12), 183190, 2005.

5. S Chen and J Singh, Controlled release of levonorgestrel from smart polymer systems: In vitro evaluation. Pharmaceutical Development and Technology, 10, 319325, 2005.

6. Brahma N Singh, Romi Singh and Jagdish Singh, Effects of ionization and penetration enhancers on the transdermal delivery of 5fluorouracil through excised human stratum corneum. International Journal of Pharmaceutics, 298, 98107, 2005.

7. Khaled ALTahami, Amanda Myer, and Jagdish Singh, Polylactic acid based injectable delivery systems for controlled release of a model protein,lysozyme. Pharmaceutical Development and Technology, Accepted for publication, 2005.

8. Feirong Kang and Jagdish Singh, In vitro release of insulin and biocompatibility of in situ forming gel systems. International Journal of Pharmaceutics. Accepted for Publications, 2005.

9. Feirong Kang and Jagdish Singh, Preparation, in vitro release, in vivo absorption and biocompatibility studies of insulin loaded microspheres in rabbits. AAPS PharmSciTech, Accepted for Publication, 2005.

10. Babu Medi and Jagdish Singh, Prospects of vaccines for allergic and immunological skin disorders. American Journal of Clinical Dermatology, submitted, 2005.

11. Sumeet K. Rastogi and Jagdish Singh, Iontophoretic enhancement of leuprolide acetate by fatty acids, limonene and depilatory lotions through porcine epidermis. Pharmaceutical Development and Technology, 9 (4), 341348, 2004.

12. Somnath Singh and Jagdish Singh, Dermal toxicity and microscopic alterations in vivo in rabbit by components of JP8 jet fuel, Environmental Toxicology and Pharmacology, 16(3), 153 161, 2004.

13. Somnath Singh and Jagdish Singh, Controlled Release, conformational stability, and biological activity of lysozyme from phase sensitive smart polymer based delivery systems. International Journal of Pharmaceutics, 271, 189196, 2004.

14. Feirong Kang and J Singh, Conformational stability of a model protein (Bovine Serum Albumin) during primary emulsification process of PLGA microspheres synthesis. International Journal of Pharmaceutics, 260, 149156, 2003.

15. Somnath Singh and Jagdish Singh, Percutaneous absorption, biophysical, and macroscopic barrier properties of porcine skin exposed to major components of JP8 jet fuel. Environmental Toxicology and Pharmacology, 14, 7785, 2003.

16. Sumeet Rastogi and Jagdish Singh, Mechanism of transport enhancement of insulin through porcine epidermis by depilatories: Permeability and FTIR studies. AAPS PharmSciTech, 4(3), article 29, 2003.

17. Somnath Singh, Kaidi Zhao and Jagdish Singh, In vivo percutaneous absorption, skin barrier Perturbation and irritation from JP8 jet fuel components. Drug and Chemical Toxicology, 26, 135146, 2003.

18. Somnath Singh and Jagdish Singh, Effect of polyols on the conformational stability and biological activity of a model protein lysozyme. AAPS PharmSci Tech, 4(3), article 42, 2003.

19. Babu Medi and Jagdish Singh, Electronically facilitated transdermal delivery of human parathyroid hormone (134). International Journal of Pharmaceutics, 263, 2533, 2003.

20. Sumeet K Rastogi and Jagdish Singh, Transepidermal transport enhancement of insulin by lipid extraction and iontophoresis. Pharmaceutical Research,19, 427433, 2002.

21. Jiang G, Woo BH, Kang F, Singh J, and DeLuca PP., Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly (d,llactidecoglycolide) microspheres. Journal of Controlled Release, 79, 1371451, 2002.

22. Feirong Kang, Ge Jiang, Ann Hinderliter, Patrick P DeLuca, and Jagdish Singh, Stability of a model protein, lysozyme, during emulsification for preparation of lysozymeloaded PLGA microspheres. Pharmaceutical Research,19, 629633, 2002.

23. Matthew J Schaefer and Jagdish Singh, Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres. Biomaterials, 23, 34653471, 2002.

24. Somnath Singh, Kaidi Zhao, and Jagdish Singh, In vitro permeability and binding of hydrocarbons in pig ear and human abdominal skin. Drug and Chemical Toxicology, 25(1), 8392, 2002.

Book Chapters: 1. Babu Medi, Somnath Singh and Jagdish Singh, Assessing Efficacy of Penetration Enhancers. In Dermal Absorption Models in Toxicology and Pharmacology (JE Riviere, Ed.), Taylor and Francis, 211247, 2005.

2 Babu Medi and Jagdish Singh, Electroporation. In Percutaneous Penetration Enhancers, Vol. 2 (Smith E, Maibach HI, Eds.), CRC Press, In Press, 2005.

3. Shitut, SK Rastogi, S Singh, F Kang, and J Singh, Rectal and Vaginal Routes of Delivery. In Theory and Practice of Contemporary Pharmaceutics, CRC Press, Florida, Chapter 15, pp 447 470, 2004.


B. Medi and J Singh, Electroporation is Superior to Liposome and Sonoporation for Cutaneous DNA Vaccine Delivery. To be presented at 32 nd Annual Meeting and Exposition of the Controlled Release Society, Miami Beach, Florida, USA, June 1822, 2005.

S. Chen and J Singh, Controlled Release of Growth Hormone from Thermosensitive Triblock Copolymer: In Vitro and In Vivo Evaluation. To be presented at 32 nd Annual Meeting and Exposition of the Controlled Release Society, Miami Beach, Florida, USA, June 1822, 2005.

Khaled AlTahami and Jagdish Singh, In vitro release of insulin from in situ gel forming smart polymers. Presented at 4 th Engebretson Symposium on Drug Discovery and Development, University of Minnesota, Minneapolis, June 9, 2005.

A. Basarkar and J Singh, Controlled gene delivery using cationic microparticles in vitro. Presented at 4 th Engebretson Symposium on Drug Discovery and Development, University of Minnesota, Minneapolis, June 9, 2005.

S Chen and J Singh, Controlled release of growth hormone from thermosensitive triblock copolymer: In vitro and in vivo evaluation. Presented at 4 th Engebretson Symposium on Drug Discovery and Development, University of Minnesota, Minneapolis, June 9, 2005.

S Singh, DC Webster and J Singh, Smart polymerbased controlled release formulations of leuprolide acetate for suppression of testosterone level in vivo in rabbits. Presented at 4 th Engebretson Symposium on Drug Discovery and Development, University of Minnesota, Minneapolis, June 9, 2005.

B Medi and J Singh, Electroporation mediated cutaneous DNA vaccine delivery. Presented at 4 th Engebretson Symposium on Drug Discovery and Development, University of Minnesota, Minneapolis, June 9, 2005.

J Singh, Electronically facilitated delivery of proteins and DNA vaccines, Plenary lecture, Indian Pharmaceutical Congress, Kolkata, December 35, 2004.

J Singh, Skin targeted DNA vaccine delivery by electroporation, invited lecture, Exogenous Dermatology Symposium II, Weimar, Germany, July 1011, 2004.

J Singh, Electronically facilitated transdermal delivery of protein and gene, invited lecture, College of Pharmacy, University of Marburg, July 8, 2004.

J. Singh, NDSU Economic Development Day: Pharmacy/Bitech perspectives. Invited lecture, NDSU Tech Park 1, August 12, 2004.

J. Singh, B. Medi. Cutaneous gene delivery using electroporation: effect of electroporation parameters. Presented at AAPS 2004, Baltimore, MD. November 711, 2004.

S. Rastogi, J. Singh. In vitro and in vivo iontophoretic transdermal delivery of lispro insulin: effect of chemical enhancers. Presented at AAPS 2004, Baltimore, MD. November 711, 2004.

S. Singh, T. Gustad, J. Singh. Biocompatibility and biodegradability of smart polymer based in situ gel forming controlled release drug systems. Presented at AAPS 2004, Baltimore, MD. November 711, 2004.

J. Singh, F. Kang. In vivo absorption of insulin from microspheres and biocompatibility. Presented at AAPS 2004, Baltimore, MD. November 711, 2004.

S. Chen, R. Pieper, D. Webster, J. Singh. Biodegradable in situ gel forming copolymers for delivery of contraceptive hormone. Presented at AAPS 2004, Baltimore, MD. November 711, 2004.

F. Kang, J. Singh. In vitro insulin release from in situ forming gel system for basal insulin delivery. Presented at AAPS 2004, Baltimore, MD. November 711, 2004.

S. Chen, R. Pieper, D. Webster, J. Singh. Controlled release of a model protein from biodegradable thermosensitive triblock copolymers. Presented at AAPS 2004, Baltimore, MD. November 711, 2004.

B. Medi, J. Singh. Skin targeted DNA vaccine delivery using electroporation: efficacy and safety. Presented at AAPS 2004, Baltimore, MD. November 711, 2004.

Sibao Chen, Robert Pieper, Dean C. Webster and Jagdish Singh. Biodegradable thermosensitive triblock copolymer PLGAPEGPLGA for delivery of protein. Presented at ENGEBRETSON SYMPOSIUM 2004, Fargo, ND, May 1011, 2004.

Sibao Chen, Robert Pieper, Dean C. Webster and Jagdish Singh. Controlled release of contraceptive hormones from in situ gel forming thermosensitive copolymers. Presented at ENGEBRETSON SYMPOSIUM 2004, Fargo, ND, May 1011, 2004.

Feirong Kang and Jagdish Singh. The biocompatibility and in vitro insulin release from in situ forming gel system. Presented at ENGEBRETSON SYMPOSIUM 2004, Fargo, ND, May 1011, 2004.

Feirong Kang and Jagdish Singh. In vivo absorption and biocompatibility of insulinloaded microspheres. Presented at ENGEBRETSON SYMPOSIUM 2004, Fargo, ND, May 1011, 2004.

Babu M. Medi and Jagdish Singh. In vivo nonviral cutaneous gene delivery using electroporation. Presented at ENGEBRETSON SYMPOSIUM 2004, Fargo, ND, May 1011, 2004.

Babu M. Medi and Jagdish Singh. Skin targeted DNA vaccine delivery using electroporation: efficacy and safety. Presented at ENGEBRETSON SYMPOSIUM 2004, Fargo, ND, May 1011, 2004.

Sumeet K. Rastogi and Jagdish Singh. Percutaneous absorption enhancement of insulin in diabetic rabbits. Presented at ENGEBRETSON SYMPOSIUM 2004, Fargo, ND, May 1011, 2004.

Somnath Singh, Dean C. Webster and Jagdish Singh. Controlled release of protein and peptide from in situ gel forming thermosensitive polymers. Presented at ENGEBRETSON SYMPOSIUM 2004, Fargo, ND, May 1011, 2004.

J. Singh, B. M. Medi. Effect of Electroporation on Skin Barrier Function, Irritation and Viability In Vivo. Presented at 2003 AAPS Annual Meeting and Exposition, Salt Lake City, Utah, October 2630, 2003.

J. Singh, S. K. Rastogi. Effect of Limonene on the In Vitro Iontophoretic Transport of Insulin Through Porcine epidermis. Presented at 2003 AAPS Annual Meeting and Exposition, Salt Lake City, Utah, October 2630, 2003.

S. Chen, J. Singh. Iontophoretic Transport Enhancement of Growth HormoneReleasing Hexapeptide (GHRP6) Though Dermatomed Porcine Skin. Presented at 2003 AAPS Annual Meeting and Exposition, Salt Lake City, Utah, October 2630, 2003.

S. K. Rastogi, J. Singh. In Vivo Percutaneous Absorption Enhancement of Lispro Insulin In Rabbits. Presented at 2003 AAPS Annual Meeting and Exposition, Salt Lake City, Utah, October 2630, 2003.

B. M. Medi, J. Singh. In Vivo Cutaneous Delivery of Hepatitis B DNA Vaccine Using Electroporation. Presented at 2003 AAPS Annual Meeting and Exposition, Salt Lake City, Utah, October 2630, 2003.

B. M. Medi, J. Singh. Electroporation Mediated NonViral Cutaneous Gene Delivery In Vivo in Rabbits. Presented at 2003 AAPS Annual Meeting and Exposition, Salt Lake City, Utah, October 2630, 2003.

S. Chen, J. Singh. Controlled Release of Levonorgestrel from Biodegradable and Injectable Smart Polymer Formulations. Presented at 2003 AAPS Annual Meeting and Exposition, Salt Lake City, Utah, October 2630, 2003.

F. Kang, J. Singh. Basal Insulin Delivery from Biodegradable and In Situ Forming Gel Formulations. Presented at 2003 AAPS Annual Meeting and Exposition, Salt Lake City, Utah, October 2630, 2003.

J. Sing, T. R. Gustad, S. Singh. Biocompatible and IN Situ Gel Forming Phase Sensitive Smart Polymer Formulations for Controlled Release of Proteins in Biologically Active Form. Presented at 2003 AAPS Annual Meeting and Exposition, Salt Lake City, Utah, October 2630, 2003.

S. Sing, T. R. Gustad, D. C. Webster, J. Singh. Controlled Release of Model Proteins from Biocompatible and Thermosensitive Smart Polymer Formulations. Presented at 2003 AAPS Annual Meeting and Exposition, Salt Lake City, Utah, October 2630, 2003.

S. Chen, J. Singh. Iontophoretic Transport Enhancement of Growth HormoneReleasing Hexapeptide 9GHRP6) Though Dermatomed Porcine Skin. Presented at 4 th Biennial ND/SD Joint EPSCoR Conference, Fargo, ND, September 5, 2003.

B. M. Medi, J. Singh. NonViral Gene Delivery to Skin using Electroporation. Presented at 4 th Biennial ND/SD Joint EPSCoR Conference, Fargo, ND, September 5, 2003.

J. E. Suchor, S. Chen, J. Singh. Smart Polymer Based Controlled Release Drug Delivery System for Testosterone. Presented at 4 th Biennial ND/SD Joint EPSCoR Conference, Fargo, ND, September 5, 2003.

Babu Medi and Jagdish Singh, In vivo cutaneous gene delivery using electroporation. 30 th Annual meeting of Controlled Release Society, Glasgow, Scotland, July 1923, 2003.

S. Singh and J. singh, Smart polymer based controlled release formulation of a model protein bromelain. 30 th Annual meeting of Controlled Release Society, Glasgow, Scotland, July 1923, 2003

J. Singh: Invited lecture on "Conformational stability and delivery of proteins from biodegradable microspheres", International Symposia "PARTICLES 2002", 2023 April 2002, Orlando, Florida.

J Singh: Invited Plenary Lecture on "Electronically facilitated transdermal delivery of biotechnologically derived molecules", 54 th Indian Pharmaceutical Congress, Pune, India, December 1315, 2002.

N. R. Shitut, S. Singh, and J. Singh. Preparation, characterization and targeting of 5fluorouracil loaded PLGA microspheres suitable for passive targeting to the lungs. Presented at the 2002 AAPS Annual Meeting and Exposition, in Toronto, Ontario, Canada on November 1014, 2002.

S. Chen and J. Singh. In vitro iontophoretic delivery of Growth HormoneReleasing hexapeptide (GHRP6) through the porcine skin. Presented at the 2002 AAPS Annual Meeting and Exposition, in Toronto, Ontario, Canada on November 1014, 2002.

B. M. Medi, S. Chen, R. K. Yan, and J. Singh. Effect of the concentration and valence of electrolytes on electroosmotic water flow during Transdermal Iontophoresis. Presented at the 2002 AAPS Annual Meeting and Exposition, in Toronto, Ontario, Canada on November 1014, 2002.

B. M. Medi and J. Singh Electroporation/Iontophoresis Facilitated Transdermal Delivery of Human Parathyroid Hormone (134). Presented at the 2002 AAPS Annual Meeting and Exposition, in Toronto, Ontario, Canada on November 1014, 2002.

J. Singh and S. Singh. In situ gel depot forming polymer as controlled drug delivery system for a model protein lysozyme. Presented at the 2002 AAPS Annual Meeting and Exposition, in Toronto, Ontario, Canada on November 1014, 2002.

S. Singh and J. Singh. Evaluation of preservatives for protein formulations by differential scanning calorimeter using a model protein lysozyme. Presented at the 2002 AAPS Annual Meeting and Exposition, in Toronto, Ontario, Canada on November 1014, 2002.

S. Singh and J. Singh. Skin barrier perturbation, irritation, and microscopic alterations in vivo in rabbit from JP8 jet fuel. Presented at the 2002 AAPS Annual Meeting and Exposition, in Toronto, Ontario, Canada on November 1014, 2002.

S. K. Rastogi and J. Singh. Transdermal transport enhancement of leuprolide acetate by depilatories: permeability and FTIR studies. Presented at the 2002 AAPS Annual Meeting and Exposition, in Toronto, Ontario, Canada on November 1014, 2002.

J. Singh and S. K. Rastogi. Effect of iontophoresis and fatty acids on the in vitro transdermal transport of leuprolide acetate. Presented at the 2002 AAPS Annual Meeting and Exposition, in Toronto, Ontario, Canada on November 1014, 2002.

J. Singh and F. Kang. Conformational stability and biological activity of chymotrypsin during PLGA microspheres synthesis. Presented at the 2002 AAPS Annual Meeting and Exposition, in Toronto, Ontario, Canada on November 1014, 2002.

F. Kang and J. Singh. Effect of SDS on the conformational stability of a model protein during w/o emulsification process. Presented at the 2002 AAPS Annual Meeting and Exposition, in Toronto, Ontario, Canada on November 1014, 2002.

DeLuca PP, Kang F, Singh J and Jiang G, Protein extraction from PLGA microspheres using PEG: Protein content determination and stability assessment. Presented at the 2002 AAPS Annual Meeting and Exposition, in Toronto, Ontario, Canada on November 1014, 2002.

J Singh and SK Rastogi, Formation of electrically conductive polar pathways by SC lipid extraction for passive and iontophoretic transport of peptides, 8th International Conference on Perspectives in Percutaneous Penetration, 26 April, 2002, Antibes JuanLes Pins, France.

S Singh and J Singh, Evaluation of stabilizers against destabilization of a model protein lysozyme due to oxidation by hydrogen peroxide. Presented at 29 th Annual meeting of Controlled Release Society, Seoul, Korea, July 2025, 2002.

G Jiang, F Kang, K Na, J Singh and P DeLuca, Strategies for protein extraction from PLGA microspheres: Protein content and stability. Presented at 29 th Annual meeting of Controlled Release Society, Seoul, Korea, July 2025, 2002.

J Singh and SK Rastogi, Passive and iontophoretic transepidermal transport enhancement of peptides. Presented at 29 th Annual meeting of Controlled Release Society, Seoul, Korea, July 20 25, 2002.


My research efforts are directed towards the mechanistic studies for developing novel delivery technologies to deliver peptide, protein and DNA.

K. Present Professional Interests and Activities Member of the following professional organizations:

USP, Golden Key, AACP, AAPS, CRS, APTI, and AAAS Fellow, AAPS



A. Information

Name: Robert K. Sylvester Date of Birth: 7201948

Department/Division: Pharmacy Practice Licensed Pharmacist? Yes: State ND, MN

First title at College: Associate Professor Date appointed: 811989 Current title: Associate Professor Date appointed: 811989


Activity Per cent (%) Teaching: Didactic 20% Experiential 25%

Practice 40% Scholarly activity 10% Committee assignments 3% Student advising 1% Faculty mentoring 1% Administration Other:

Total 100%

EE. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences) Neoplastic Diseases (Ph Pract 535); elective clerkship – Oncology at MeritCare Hospital; elective clerkship – Supportive Care at Hospice of Red River Valley; Pharmaceutical Care – Service Learning


College Dates attended Degree Earned South Dakota State University 9/1966 to 5/1971 B.S.

College Dates attended Degree Earned University of Minnesota 9/1974 to 5/1976 Pharm. D.






Institution Dates of employment Position University of Minnesota 1979 – 1989 Clinical Assistant Professor


Oncology Infections in Patients with Cancer, PSAP V – in press

Sylvester RK, Lindsay SM, Schauer C: The Conversion Challenge: From Intrathecal to Oral Morphine. J of Hospice Palliative Care Med 2004;21:143-7.

Sylvester RK: Ten years of colony-stimulating factors: what have we learned? AmJ Health-Syst Pharm. 2002;59(Suppl 2):S3-5.

Sylvester RK: Clinical applications of colony-stimulating factors: a historical perspective. AmJ Health-Syst Pharm. 2002;59(Suppl 2):S6-12.


“Optimizing Use of Colony Stimulating Factors Through Therapeutic Equivalence” Cleveland Clinic Hematology/Oncology Fellows Cleveland, OH May 19, 2005

“Changing Equianalgesic Conversion Charts to MD Anderson Method” Medical Advisory Committee Meeting, Hospice of Red River Valley Fargo, ND April 25, 2005

“Outcomes of Chemotherapy in the Older Adult: Anecdotal vs. Scientific Evidence” Leukemia & Lymphoma Society – New York City Chapter NY Presbyterian Hospital, New York, NY March 18, 2005 “Evaluation of Proton Pump Inhibitor Use in Hospice Patients Medical Advisory Committee Meeting, Hospice of Red River Valley Fargo, ND February 8, 2005

“Appropriate Use of Erythropoetin in Palliative Care” Medical Advisory Committee Meeting, Hospice of Red River Valley Fargo, ND February 17, 2003

“Overview of Oncology Drugs” University of North Dakota – School of Medicine and Health Sciences, P. A. Program September 29, 2003

“Pain and Symptom Management – Advanced Level” Geriatric Healthcare Alzheimer’s and North Dakota Hospice Organization Annual Joint Meeting Bismarck, ND October 10, 2003

“The Role of Growth Factors in Oncology” South Dakota Society of HealthSystem Pharmacy – Annual Meeting Sioux Falls, SD March 17, 2002

“Filgrastim and Sargramostim: Are They Therapeutically Equivalent?” Tripler Army Hospital Grand Rounds – Departments of Oncology and Pharmacy Honolulu, HA March 15, 2002

“The War on Cancer: An Update from the Front” American Association of Pharmacy Technicians Annual Meeting Fargo, ND – August 1, 2002


Supportive care of oncology patients; comparative effectiveness of methadone; topical methadone


ND Pharmacist's Association, AACP, ACCP, AHSP, Eastern Cooperative Oncology Group – Pharmacist Committee,



A. Information

Name: Justin M. Welch Date of Birth: 10/17/71

Department/Division: Pharmacy Practice Licensed Pharmacist? Yes: State: ND





Practice 10 Scholarly activity 10 Committee assignments 5 Student advising 8 Faculty mentoring 1 Administration Other: 1

Total 100%

FF. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences)

Current: • Pharm 300: Principles of Clinical Pharmacology (fall) – Course Coordinator, 18 hrs, several

coinstructors. • Pharm 538: Cardiovascular and Pulmonary (fall) – Anticoagulation lectures. 12 hrs. • Pharm 58123. Adult Medicine Clerkship – Internal medicine. 35 weeks, 14 students. • University 189: Skills for Academic Success (Fall) – 2 sections, 32 hrs • Community of Caring Leaders and Problems Solvers, cofaculty advisor for prepharmacy

cohort. – 25 freshmen advisees/annually • Clinical Cases for Concept lab: Heart Failure and CVA/A.fib/PVD author/proctor. • Pharmacy Practice Residency Preceptor, Adult Medicine. – 4 months. • P3 Service Learning advisor

Previously taught: • Pharm 535: Hematology and Neoplastic Disease (spring) – Hematology section. 12 hrs. and

home study modules in hematology for 2004.


College Dates attended Degree Earned North Dakota State University 8/905/96 B.S. in Pharmaceutical Science


College Dates attended Degree Earned North Dakota State University 8/965/98 Doctor of Pharmacy


Institution Dates attended Position VA Medical Center 7/98 – 6/00 Pharmacy Practice Resident Fargo, ND




Welch, J.M. "A Practical Approach to the Management of Heart Failure" U.S. Pharm. July 2004 29(7):HS17HS22.

Rising, S.E., Welch, J.M., Koo, J.M. “Association of Mortality Risk with High Serum Digoxin Concentrations” Hospital Pharmacy In press

Webb, M., Koo, J.M., Welch, J.M., Doetkott, M.S. “Factors Associated with Epoetin Response in Elderly Patients: an Epoetin Utilization Review” submitted to Hospital Pharmacy


• Invited lecture for Villa Maria residents “Stomach Health: Common Ailments, Prevention and Selfmedication”


• Clinical instruction, developing methods to assess learning and to promote retention • Collaboration with pharmacy practice resident on a retrospective research and manuscript


• Peer reviewer for U.S. Pharmacist • Peer review of teaching with colleague, several classroom observations • Student advising and mentoring through CCLP and University 189 • Preceptor of the Year, 2005 and 2003 • Faculty advisor for Rho Chi, Kappa chapter • Board Certified Pharmacotherapy Specialist, since 2002, using PSAP for

recertification credits (50 CE from PSAP V) • Active learning and problem based learning. Revising Phrm 538 to utilize classroom

time for problem based learning (no traditional lecture), students are given materials to prepare prior to class time and expected to participate in discussions, small groups, and by using PRS.

• ACCP member, attended spring meeting and will attend annual meeting • AACP member, have attended annual meeting



A. Information

Name: Ross M. Wilhelm Date of Birth:02/14/1973


First title at College: Lecturer Date appointed: Fall 1999

Current title: Assistant Professor Date appointed: Fall 2004


Activity Percent (%) Teaching: Didactic

60

Experiential Included in above figure Practice 20 Scholarly activity 5 Committee assignments 5 Student advising 5 Faculty mentoring 0 Administration 5 Other:

Total 100%

GG. Teaching Responsibilities: List teaching responsibilities, during academic year of onsite evaluation; if different from previous years indicate (e.g. courses taught, include team teaching, practice experiences) Pharm 352 Lectures Pharm 451 and 452 Lectures Pharm 551 Lectures Pharm 351/352 Concept Pharmacy Labs Pharm 451/452 Concept Pharmacy Labs Pharm 551/552 Concept Pharmacy Labs

HH. Postsecondary/Professional Education

College Dates attended Degree Earned University of North Dakota Fall 19911993 PrePharmacy Ed

College Dates attended Degree Earned North Dakota State University Fall 1993Spring 1996 Bachelor of Pharm. Science

College Dates attended Degree Earned North Dakota State University Fall 1994Spring 1998 Pharm. D.

II. Graduate Education (Master of Science, Doctor of Philosophy)







NONE


NONE


AACP Innovations in Teaching submission involving the Concept Pharmacy education piece of our curriculum.

PDA Education and Technology Grant received and currently being implemented in the Concept Pharmacy.


Community Practice of Pharmacy Independent Pharmacy Practice Medicare Part D Currently Manager of The Medicine Shoppe Pharmacy in Fargo

Preceptor in Community Advanced Practice site for P4 students at the Medicine Shoppe and preceptor for P4 students in an Academic rotation in the Concept Pharmacy Faculty advisor for NCPA student chapter at NDSU

h. publications during the past three years...2003present editorial board member, drug design...

Documents